Amphetamines Test Evidence
Has Caused a False Positive
Bisoprolol
Source Pope et al., J Anal Toxicol 2023
What It Found
- Bisoprolol reacted with CEDIA at 400 micrograms/mL in spiked urine.
Test Studied
- CEDIA Amphetamine/Ecstasy
Source Sainz-Pastor et al., Scand J Clin Lab Invest 2026
What It Found
- In a small emergency-department comparison, investigators also associated one unconfirmed lateral-flow result with bisoprolol.
Test Studied
- Clinical lateral-flow assay
Both sources Pope et al., J Anal Toxicol 2023 Sainz-Pastor et al., Scand J Clin Lab Invest 2026
Keep in Mind
- The high laboratory concentration and isolated clinical association limit prediction for usual treatment.
Buflomedil
Source Papa et al., Eur J Clin Chem Clin Biochem 1997
What It Found
- Patient urine and drug-free urine spiked with buflomedil yielded false positives on the monoclonal reagent.
- The polyclonal test was negative in that study.
Keep in Mind
- The authors also suspected metabolite effects.
- The finding concerns a historical reagent and medicine.
Test Studied
- Monoclonal EMIT d.a.u. amphetamine/methamphetamine
Bupropion
Source Casey et al., J Med Toxicol 2011
What It Found
- In a hospital chart review, bupropion was a recorded prescription in 53 of 128 emergency department amphetamine screens that failed confirmation.
Keep in Mind
- Chart review: it started from positive screens, so it cannot say how often a person taking bupropion as prescribed will test positive.
Test Studied
- Chart review: the Syva EMIT II Plus urine amphetamine screen, with every positive checked by gas chromatography
3 sources Reidy et al., Ther Drug Monit 2011 Marin et al., J Anal Toxicol 2016 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- Laboratory and specimen studies implicate bupropion metabolites, including hydroxybupropion and erythrohydrobupropion.
Keep in Mind
- Laboratory studies: the results apply to the kits tested.
Source Rivas-Coppola et al., Pediatr Neurol 2015
What It Found
- A separate case report describes a presumptive amphetamine result in an infant with a severe bupropion overdose.
Keep in Mind
- Case report: the infant's exposure was an overdose, not a prescribed dose, and the abstract does not name the test or say how the result was checked.
Tests Studied
- Case report: a urine amphetamine screen in an infant
- The abstract does not name the test
Source Reidy et al., Ther Drug Monit 2011
Test Studied
- Laboratory and specimen studies: amphetamine ELISA kits, including Amphetamine ULTRA
2 sources Marin et al., J Anal Toxicol 2016 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
Test Studied
- Other amphetamine screens
Chloroquine
Source Gomila et al., Ther Drug Monit 2017
What It Found
- After a large ingestion, two urine samples tested positive on DRI.
- Added chloroquine also reacted with DRI and EMIT II Plus.
Keep in Mind
- Patients taking chloroquine therapeutically for rheumatoid arthritis did not have false positives in this study.
Tests Studied
- DRI Amphetamine
- EMIT II Plus Amphetamines in fortified urine
Cyclamate
Source Martz and Schütz, Clin Chem 1991
What It Found
- An unconfirmed result led investigators to identify urinary cyclohexylamine, a possible cyclamate metabolite.
- They reproduced cross-reactivity with cyclohexylamine in the TDx system.
Keep in Mind
- Cyclamate is a sweetener.
- Metabolite production varied, and the study did not establish that typical intake causes a positive.
Test Studied
- Abbott TDx amphetamine class immunoassay
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 5% for cyclohexylamine, a cyclamate metabolite relative response.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
Dimethylamylamine
Source Vorce et al., J Anal Toxicol 2011
What It Found
- A military investigation detected DMAA by LC-MS/MS in 92.3% of 134 selected specimens that screened positive but failed GC-MS confirmation for amphetamines.
Keep in Mind
- The sample consisted of unconfirmed positives.
- This fraction is not the probability of an interference for someone exposed to DMAA.
Test Studied
- Two immunoassays used in U.S. military urine screening
Source Łukasik-Głebocka et al., Przegl Lek 2013
What It Found
- A multi-ingredient Thermal Pro overdose case named DMAA or bitter orange components as possible explanations for an unconfirmed amphetamine screen.
Keep in Mind
- Both ingredients and multiple other substances were present.
- The study did not test them separately in this patient's urine.
Test Studied
- Abbott AxSYM amphetamine/methamphetamine FPIA with LC-MS/MS
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Dimethylamylamine challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 50 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 5 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 4.2% relative response to Dimethylamylamine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
Esmolol
Source Hughey and Colby, Clin Chem 2019
What It Found
- Both esmolol and esmolol acid reacted in laboratory urine testing.
Keep in Mind
- The experimental concentrations were high.
Test Studied
- Abbott MULTIGENT amphetamines, 500 ng/mL
Source Adashek et al., Cureus 2021
What It Found
- A separate report described a false-positive urine screen during esmolol administration.
Both sources Hughey and Colby, Clin Chem 2019 Adashek et al., Cureus 2021
Keep in Mind
- Neither study gives an individual risk estimate.
Imatinib
Source Hughey and Colby, Clin Chem 2019
What It Found
- The reference-standard experiment produced a positive screen at 216.6 micrograms/mL.
Test Studied
- Abbott MULTIGENT amphetamines
Source Meyers and Wachman, J Addict Med 2021
What It Found
- A separate patient had recurrent positive screens after restarting imatinib and negative maternal urine GC-MS.
Keep in Mind
- An isolated clinical report cannot distinguish the contribution of imatinib from its metabolites or establish how often this occurs.
Test Studied
- Maternal clinical immunoassay
Kava
Source Madhavaram et al., J Anal Toxicol 2020
What It Found
- Three unconfirmed urine screens contained kavain, a kava constituent.
- Tested kava powders and purified kavain reacted with the screen.
- GC-MS found no amphetamine-type substances.
Keep in Mind
- The concentration of kavain varies among preparations.
- The study did not establish a serving size that predicts a positive.
Test Studied
- CEDIA amphetamine immunoassay
Labetalol
Source Gilbert et al., J Anal Toxicol 1995
What It Found
- The urinary metabolite 3-amino-1-phenylbutane reacted with several amphetamine screens.
2 sources Yee and Wu, Obstet Gynecol 2011 Karnani-Khemlani et al., Clin Chem Lab Med 2026
What It Found
- Positive results have been reported in pregnancy.
Source Karnani-Khemlani et al., Clin Chem Lab Med 2026
What It Found
- In one case the urine tested positive on a cassette and negative on CEDIA.
Keep in Mind
- The reactive compound was tentative in the cassette case.
Test Studied
- Nal von minden Multi 10TD AMP1000 versus CEDIA
Source Wilson and Smith, Ann Clin Biochem 1999
What It Found
- A UK external quality assessment included a specimen fortified with labetalol at 5 µg/L.
- Across the six amphetamine-interferent challenges, some laboratories reported amphetamine.
Keep in Mind
- The investigators pooled the error range across the challenges, which used different laboratory methods.
- It cannot establish a specific reagent or probability for a patient.
Test Studied
- UK NEQAS urine proficiency testing across multiple laboratories
Source Bithi et al., J Addict Med 2023
Keep in Mind
- Adding the parent drug to urine produced no positives in a separate study.
2 sources Gilbert et al., J Anal Toxicol 1995 Bithi et al., J Addict Med 2023
Keep in Mind
- Metabolite exposure and assay selection matter.
2 sources Gilbert et al., J Anal Toxicol 1995 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
Test Studied
- Abbott TDx II, Syva EMIT d.a.u
Mesocarb
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- Both assays showed reactivity with Mesocarb in the authors’ stimulant study.
Keep in Mind
- This finding is specific to the historical reagents and administered products.
Test Studied
- Abbott Amphetamine Class and Amphetamine/Methamphetamine II FPIA
Methoxyphenamine
Source Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
What It Found
- The manufacturer observed a cutoff-equivalent response to methoxyphenamine added to drug-free urine.
Keep in Mind
- The experiment used concentrated drug in urine and did not measure effects at ordinary doses.
Test Studied
- EMIT II Plus Amphetamines, table 23
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- Both assays showed reactivity with Methoxyphenamine in the authors’ stimulant study.
Keep in Mind
- This finding is specific to the historical reagents and administered products.
Test Studied
- Abbott Amphetamine Class and Amphetamine/Methamphetamine II FPIA
Methyldopa
Source Hughey and Colby, Clin Chem 2019
What It Found
- An EHR-based study reproduced interference with the metabolite alpha-methyldopamine at 13.6 micrograms/mL.
- Parent methyldopa and 3-O-methyldopa were negative under the tested conditions.
Keep in Mind
- The spiking experiment concerns a metabolite concentration, not an oral dose.
Test Studied
- Abbott MULTIGENT amphetamines, 500 ng/mL
Source Sayer ÖN et al., Indian J Psychiatry 2026
Keep in Mind
- A pregnancy case also reported a presumptive false positive.
Methylene blue
Source Leegwater and Jager, Ther Drug Monit 2026
What It Found
- A published report describes two false-positive urine amphetamine screens associated with methylene blue.
Keep in Mind
- The two-case report has no indexed abstract identifying its assay or confirmation method.
Test Studied
- The assay used in a separate two-case report is unverified
Source Stevic et al., Clin Biochem 2025
What It Found
- In a separate laboratory study, adding more than 0.08 mg/L methylene blue to urine increased the signal on the Roche cobas c702 amphetamines assay.
Keep in Mind
- The laboratory threshold identifies measurable positive bias.
- It does not establish the concentration at which a previously negative specimen would be reported positive.
Test Studied
- Roche cobas c702 urine amphetamines assay in a laboratory study
Metoprolol
Source Leclercq et al., J Anal Toxicol 2020
What It Found
- After metoprolol poisoning, two patients had positive screens with negative GC-MS confirmation.
- In spiked urine, metoprolol and two metabolites reacted with the Abbott amphetamine screen.
Keep in Mind
- Poisoning and high-concentration spiking do not establish the risk from a usual prescription.
Test Studied
- Abbott MULTIGENT amphetamine/methamphetamine
Mexiletine
Source Snozek et al., Clin Biochem 2018
What It Found
- Urine from two mexiletine-treated patients screened positive on all four named assays and was negative for amphetamines by mass spectrometry.
- Adding mexiletine to drug-free urine reproduced the reactions.
Keep in Mind
- The concentration needed to trigger a result varied between assays.
Test Studied
- Syva EMIT II Plus, Roche KIMS, Noble Split-Specimen and Synchron QuikScreen in a comparative study
Source Sohal et al., Case Rep Med 2021
What It Found
- In a later case, a patient taking mexiletine had two positive urine screens followed by negative quantitative urine testing.
Keep in Mind
- The later case supplies a separate clinical observation, but the authors did not report the screening kit or measure urinary mexiletine.
Test Studied
- A separate case report did not name the screening reagent
Also cited: Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
Phentermine
2 sources Marin et al., J Anal Toxicol 2016 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- Phentermine cross-reacted in spiked urine at 7.5 micrograms/mL on EMIT II Plus.
2 sources Marin et al., J Anal Toxicol 2016 Sainz-Pastor et al., Scand J Clin Lab Invest 2026
What It Found
- Clinical studies identified phentermine in unconfirmed positives, including on an immunochromatographic screen.
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- Both assays showed reactivity with Phentermine in the authors’ stimulant study.
Keep in Mind
- This finding is specific to the historical reagents and administered products.
Test Studied
- Abbott Amphetamine Class and Amphetamine/Methamphetamine II FPIA
Source Apollonio et al., J Anal Toxicol 2007
What It Found
- In a comparison with 50 ng/mL target standards, the assay's relative response to Phentermine was 61%.
Keep in Mind
- The authors evaluated urine separately as a specimen matrix.
- The standard comparison does not show an individual post-dose positive.
Test Studied
- Bio-Quant Direct ELISA for amphetamines
Source Hamilton et al., J Anal Toxicol 2014
What It Found
- Phentermine distorted quantitation of d-amphetamine on one confirmatory GC-MS method through chromatographic interference.
Keep in Mind
- This specific effect concerned quantitation and chromatographic resolution.
- It is separate from an initial urine immunoassay result.
Test Studied
- Chiral GC-EI-MS with R-(−)-MTPA derivatization
Source Wilson and Smith, Ann Clin Biochem 1999
What It Found
- A UK external quality assessment included three specimens fortified with phentermine at 4.5 mg/L.
- Across the six amphetamine-interferent challenges, some laboratories reported amphetamine.
Keep in Mind
- The investigators pooled the error range across the challenges, which used different laboratory methods.
- It cannot establish a specific reagent or probability for a patient.
Test Studied
- UK NEQAS urine proficiency testing across multiple laboratories
3 sources Marin et al., J Anal Toxicol 2016 Sainz-Pastor et al., Scand J Clin Lab Invest 2026 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
Keep in Mind
- Phentermine is a different drug from amphetamine.
- A laboratory can identify the specific compound.
Test Studied
- Syva EMIT II Plus and clinical amphetamine immunoassays
Procainamide
Source Hughey and Colby, Clin Chem 2019
What It Found
- Procainamide and N-acetyl-3-hydroxyprocainamide each triggered this screen in fortified urine.
Test Studied
- Abbott MULTIGENT amphetamines, 500 ng/mL
Source Sainz-Pastor et al., Scand J Clin Lab Invest 2026
What It Found
- A separate clinical comparison implicated procainamide in discordant samples.
Both sources Hughey and Colby, Clin Chem 2019 Sainz-Pastor et al., Scand J Clin Lab Invest 2026
Keep in Mind
- Which reagent was used matters.
- These studies do not establish a patient-specific probability.
Psilocin
Source Tiscione and Miller, J Anal Toxicol 2006
What It Found
- A urine sample containing psilocin screened positive on the combined amphetamine/methamphetamine assay.
- A laboratory experiment also showed a small response to added psilocin.
Keep in Mind
- This involved one case and one historical combined screen.
- The study does not establish the performance of dedicated methamphetamine tests.
Test Studied
- Combined amphetamine/methamphetamine urine fluorescence polarization immunoassay
Solriamfetol
Source Kumar et al., Sleep Med 2023
What It Found
- A patient taking solriamfetol had an unexpected amphetamine screen.
- Mass spectrometry did not detect amphetamine in the solriamfetol-spiked samples.
Test Studied
- EMIT II Plus
2 sources Kumar et al., Sleep Med 2023 Rackow and Knezevic, J Anal Toxicol 2024
What It Found
- EMIT II Plus and DRI experiments reproduced cross-reactivity.
Keep in Mind
- Reagents and cutoffs differ.
Source Kumar and Ali, J Anal Toxicol 2026
Keep in Mind
- A four-platform comparison is also indexed, but its platform-specific results require full-text verification.
Tetracaine
Source Wijngaard et al., Clin Toxicol (Phila) 2021
What It Found
- Tetracaine in urethral ointment used during catheterization was detected in many unconfirmed amphetamine-positive urine samples.
- Spiking drug-free urine reproduced the signal above 40 mg/L.
Keep in Mind
- The collection procedure can introduce ointment into the sample.
- This does not establish the same effect from every tetracaine route.
Test Studied
- CEDIA Amphetamine/Ecstasy, 1,000 ng/mL
Also cited: Sainz-Pastor et al., Scand J Clin Lab Invest 2026
Trazodone
Both sources Baron et al., J Anal Toxicol 2011 Rackow and Knezevic, J Anal Toxicol 2024
What It Found
- Trazodone is converted to m-chlorophenylpiperazine (mCPP).
- This metabolite reacted with Roche and DRI screens.
Keep in Mind
- The metabolite can matter even if testing purified trazodone gives a negative result.
Source Baron et al., J Anal Toxicol 2011
What It Found
- Patient urine with measurable mCPP tested negative for amphetamine, methamphetamine and MDMA by GC-MS.
Test Studied
- Roche Amphetamines II
Chlorpromazine
Source Crane et al., Clin Chem 1993
What It Found
- All 13 chlorpromazine-treated patients in one study screened positive on monoclonal EMIT and negative on the polyclonal reagent.
- Gas chromatography found no amphetamine.
2 sources Poklis et al., Forensic Sci Int 1993 Olsen et al., Clin Chem 1992
What It Found
- Other work implicated urinary metabolites.
3 sources Poklis et al., Forensic Sci Int 1993 Olsen et al., Clin Chem 1992 Melanson et al., Arch Pathol Lab Med 2006
Keep in Mind
- Testing the parent drug alone can miss interference from urinary metabolites.
All 4 sources Poklis et al., Forensic Sci Int 1993 Olsen et al., Clin Chem 1992 Melanson et al., Arch Pathol Lab Med 2006 Crane et al., Clin Chem 1993
Test Studied
- Monoclonal EMIT d.a.u. amphetamine/methamphetamine
Ephedra
Source Nishiguchi et al., Nihon Hoigaku Zasshi 2001
What It Found
- Some patients receiving ephedra-containing herbal preparations screened positive for amphetamines.
- Follow-up HPLC or GC-MS did not verify the presumptive results.
Keep in Mind
- The investigators could not identify the individual ingredient responsible for the response.
Test Studied
- Triage urine drug-of-abuse panel
Fluspirilene
Source Crane et al., Clin Chem 1993
What It Found
- Five patients receiving fluspirilene had positive monoclonal screens.
- Polyclonal testing and gas chromatography were negative.
Keep in Mind
- This was a small series involving a historical assay.
Test Studied
- Syva EMIT d.a.u. monoclonal amphetamine, 300 ng/mL
Mebeverine
Source Kraemer et al., J Anal Toxicol 2001
What It Found
- After a single oral administration, urine screened positive for amphetamines.
- GC-MS found structurally related mebeverine metabolites, including p-methoxyamphetamine.
Keep in Mind
- Some metabolites are real amphetamine derivatives.
- This result alone cannot establish amphetamine use.
Test Studied
- Fluorescence polarization amphetamine immunoassay
Source Elliott and Burgess, J Anal Toxicol 2006
What It Found
- A forensic report describes mebeverine, mebeverine-alcohol and associated compounds as potential amphetamine immunoassay cross-reactants.
Keep in Mind
- The published fatal-case values were measured in blood.
- Those concentrations are not urine triggering thresholds.
Test Studied
- Amphetamine screening immunoassays, reagent not stated in the report abstract
Pipotiazine
Source Crane et al., Clin Chem 1993
What It Found
- Two of four patients receiving depot pipotiazine screened positive on the monoclonal test.
- All four were negative on the polyclonal test.
- Gas chromatography found no amphetamine.
Keep in Mind
- The series was small and the interval from injection to collection was uncertain.
Test Studied
- Syva EMIT d.a.u. monoclonal amphetamine, 300 ng/mL
Brompheniramine
Source Olsen et al., Clin Chem 1992
What It Found
- A historical laboratory letter implicated urinary brompheniramine metabolites in false-positive amphetamine results on monoclonal EMIT.
Keep in Mind
- The attribution was tentative.
- Combination products can also contain a decongestant with its own evidence.
Test Studied
- Monoclonal EMIT d.a.u
Etryptamine
Source Daldrup et al., Z Rechtsmed 1986
What It Found
- A report investigating fatal etryptamine intoxication describes cross-reactivity on the EMIT-st amphetamine assay.
- The drug had formerly been sold as an antidepressant.
Keep in Mind
- The report concerns severe intoxication and a historical test.
- It gives no estimate for other urine assays or exposure levels.
Test Studied
- Historical EMIT-st amphetamine assay
Fenofibrate
Source Kaplan et al., Ther Drug Monit 2012
What It Found
- A patient taking fenofibrate repeatedly screened positive on this combined amphetamine/ecstasy test.
- Definitive analysis excluded the screened drugs, and the results became negative after the prescription was discontinued.
Keep in Mind
- Separate studies tested the MDMA-specific assay.
Test Studied
- CEDIA Amphetamine/Ecstasy (combined assay)
Both sources Kaplan et al., Ther Drug Monit 2012 Dadlani et al., Australas Psychiatry 2018
Keep in Mind
- A combined-assay result does not identify a particular stimulant.
Penicillin G benzathine
Both sources García Callejo et al., Acta Otorrinolaringol Esp 1998 Badcock and Zoanetti, Clin Chem 1987
What It Found
- Older reports describe unexpected amphetamine-positive urine results after benzathine penicillin G.
- The investigators implicated the benzathine salt.
Keep in Mind
- This evidence is specific to a preparation and historical assays.
- It does not support a general penicillin-class warning.
Perazine
Source Schmolke et al., Clin Chem 1996
What It Found
- A case published in 1996 reports a false-positive amphetamine screen during perazine poisoning.
Keep in Mind
- The PubMed record lacks an abstract.
- The cited poisoning does not establish an effect at prescribed doses.
Tests Studied
- Urine amphetamine immunoassay
- Reagent unverified
Ritodrine
Source Nice and Maturen, Clin Chem 1989
What It Found
- A 1989 clinical letter reported a false-positive urine amphetamine screen associated with ritodrine.
Keep in Mind
- The indexed record does not give an assay, cutoff or estimate of frequency.
Tests Studied
- Historical urine amphetamine screen
- Exact kit unverified
Thermal Pro (studied formulation)
Source Gomółka et al., Przegl Lek 2012
What It Found
- A person who reported ThermalPro and Tisercin had an amphetamine screen that did not confirm.
- The authors suspected ingredients in the multi-ingredient stimulant supplement.
Keep in Mind
- No ingredient was isolated as the cause.
Test Studied
- Urine amphetamine screen and confirmatory HPLC-DAD in a clinical case
Source Łukasik-Głebocka et al., Przegl Lek 2013
What It Found
- A patient who took nine tablets had a positive urine screen and negative blood and urine LC-MS/MS for amphetamine.
Keep in Mind
- This is a mixed-ingredient product.
- Neither DMAA nor the bitter orange ingredients were isolated as the cause.
Test Studied
- Abbott AxSYM urine amphetamine/methamphetamine FPIA
Both sources Gomółka et al., Przegl Lek 2012 Łukasik-Głebocka et al., Przegl Lek 2013
Keep in Mind
- Product compositions can change and the result does not establish caffeine or guarana as amphetamine interferents.
Apomorphine
Source FDA 510(k) K142353. First Sign Drug of Abuse Dip Card Test and Cup Test. Interference and…, 2014
What It Found
- In the FDA specificity study, apomorphine at 50 micrograms/mL produced a positive amphetamine result.
Keep in Mind
- Fortified urine at this concentration is not evidence of a positive at routine treatment doses.
Test Studied
- First Sign urine AMP 1000 dip card and cup
Atenolol
Source Pope et al., J Anal Toxicol 2023
What It Found
- Urine fortified with atenolol at 750 micrograms/mL screened positive.
Keep in Mind
- This high-concentration experiment supplies no risk estimate for usual doses.
Test Studied
- CEDIA Amphetamine/Ecstasy, 300 ng/mL cutoff
Ceftaroline fosamil
Source Hughey and Colby, Clin Chem 2019
What It Found
- Added ceftaroline fosamil generated a positive result at an estimated 53.1 micrograms/mL.
Keep in Mind
- The tested material was the prodrug.
- The experiment does not establish urinary levels or frequency after dosing.
Test Studied
- Abbott MULTIGENT amphetamines, 500 ng/mL
Diethylstilbestrol
Source FDA 510(k) K221871. Healstone Accurate Drug of Abuse Urine Test Cup and Cup Rx…, 2022
What It Found
- The FDA submission lists positive results for diethylstilbestrol added at 2.5 micrograms/mL on AMP 500 and 5 micrograms/mL on AMP 1000.
Keep in Mind
- These values are specific to this cup and are not estimates for a prescribed dose.
Test Studied
- Healstone Accurate AMP 500 and AMP 1000 urine cup
Isometheptene
Source Levine and Caplan, Clin Chem 1987
What It Found
- A laboratory publication described EMIT cross-reactivity.
Source Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
What It Found
- Siemens also documents a cutoff-equivalent response from isometheptene in fortified urine on EMIT II Plus.
Test Studied
- EMIT II Plus Amphetamines
2 sources Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024 Siemens Healthineers. EMIT d.a.u. Amphetamine Class Assay. Instructions for use, revision…, 2024
Keep in Mind
- Different reagents required different urine concentrations.
All 3 sources Levine and Caplan, Clin Chem 1987 Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024 Siemens Healthineers. EMIT d.a.u. Amphetamine Class Assay. Instructions for use, revision…, 2024
Keep in Mind
- There is no incidence estimate for people taking an isometheptene product.
2 sources Levine and Caplan, Clin Chem 1987 Siemens Healthineers. EMIT d.a.u. Amphetamine Class Assay. Instructions for use, revision…, 2024
Tests Studied
- EMIT d.a.u
- Amphetamine Class
Metaraminol
Source Pope et al., J Anal Toxicol 2023
What It Found
- Metaraminol spiked into drug-free urine at 500 micrograms/mL triggered this assay.
Keep in Mind
- The experiment does not show that routine therapeutic exposure reaches this concentration.
Test Studied
- CEDIA Amphetamine/Ecstasy, 300 ng/mL cutoff
Moxifloxacin
Source Colby et al., Clin Biochem 2019
What It Found
- Moxifloxacin added to drug-free urine cross-reacted with the Abbott amphetamine/methamphetamine assay at concentrations the authors considered relevant to urinary exposure.
Keep in Mind
- An experiment with moxifloxacin cannot establish interference by every fluoroquinolone, formulation or test.
Test Studied
- Abbott MULTIGENT amphetamine/methamphetamine
Quinacrine
Source Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
What It Found
- Quinacrine was reactive only at very high concentrations in the manufacturer’s fortified-urine data.
- At the lowest screen cutoff studied, the tested concentration was 2.5 mg/mL.
Keep in Mind
- No patient-level evidence for routine dosing was established here.
Test Studied
- EMIT II Plus Amphetamines, table 23
Sertraline
Source Pope et al., J Anal Toxicol 2023
What It Found
- Sertraline produced a positive at 200 micrograms/mL in a spiked urine experiment.
Keep in Mind
- The tested concentration was high.
- Co-detection in patient samples cannot establish that sertraline caused their screens.
Test Studied
- CEDIA Amphetamine/Ecstasy, 300 ng/mL cutoff
Sildenafil
Source Pope et al., J Anal Toxicol 2023
What It Found
- Added sildenafil triggered a positive at 25 micrograms/mL in drug-free urine.
Keep in Mind
- Detection alongside other medicines in clinical specimens does not establish causation or how often a prescription affects the test.
Test Studied
- CEDIA Amphetamine/Ecstasy, 300 ng/mL cutoff
Tranylcypromine
Source Marin et al., J Anal Toxicol 2016
What It Found
- Tranylcypromine added to synthetic urine generated a positive screen at 20 micrograms/mL.
Keep in Mind
- This demonstrates an analytical reaction.
- It does not establish a rate during treatment.
Test Studied
- Syva EMIT II Plus Amphetamines, 300 ng/mL cutoff
Verapamil
Source Pope et al., J Anal Toxicol 2023
What It Found
- Investigators obtained a positive result with added verapamil at 1,250 micrograms/mL.
Keep in Mind
- This very high laboratory concentration does not establish a positive at usual doses.
Test Studied
- CEDIA Amphetamine/Ecstasy, 300 ng/mL cutoff
Depends on the Brand of Test
Amineptine
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- Only the Amphetamine/Methamphetamine II reagent detected Amineptine in the study.
Keep in Mind
- Responses can differ even between two assays from the same manufacturer.
Test Studied
- Abbott Amphetamine/Methamphetamine II and Amphetamine Class FPIA
Aripiprazole
Source Kaplan et al., Pediatrics 2015
What It Found
- Two children with accidental exposures screened positive with negative GC-MS.
Source Caricasole et al., Compr Psychiatry 2019
What It Found
- An adult case reported an association at prescribed oral doses.
Source Rackow and Knezevic, J Anal Toxicol 2024
What It Found
- Laboratory testing with the DRI assay did not reproduce interference from the tested substances.
Test Studied
- Thermo DRI in spiking study
All 3 sources Kaplan et al., Pediatrics 2015 Caricasole et al., Compr Psychiatry 2019 Rackow and Knezevic, J Anal Toxicol 2024
Keep in Mind
- Co-exposures and different assays limit attribution.
2 sources Kaplan et al., Pediatrics 2015 Caricasole et al., Compr Psychiatry 2019
Keep in Mind
- Oral exposure is the evidence cited here.
Test Studied
- Urine immunoassays in case reports
Atomoxetine
Source Fenderson et al., Case Rep Psychiatry 2013
What It Found
- An adult taking atomoxetine screened positive on CEDIA and negative by GC-MS.
Keep in Mind
- The case suggests an association.
- A specific reactive substance was not established in that patient.
Test Studied
- CEDIA in case report
Source Rackow and Knezevic, J Anal Toxicol 2024
What It Found
- Tests of atomoxetine and relevant metabolites in spiked urine did not reproduce this on DRI.
Test Studied
- Thermo DRI in spiking study
Cathine
Source Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
What It Found
- Norpseudoephedrine added to urine produced a response equivalent to the positive calibrator.
Test Studied
- EMIT II Plus Amphetamines
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- The authors observed a urine response after Cathine administration on the historical amphetamine class assay.
- The more selective Amphetamine/Methamphetamine II assay gave negative results for the group.
Keep in Mind
- The parent, a related metabolite or both may contribute.
- Signal strength, collection interval and the assay decision threshold matter.
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 3.6% relative response to Cathine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
Source Toennes and Kauert, Clin Chem 2002
Keep in Mind
- A study after khat exposure found several different alkaloids.
- That study cannot isolate cathine’s contribution in people.
2 sources Toennes and Kauert, Clin Chem 2002 de la Torre et al., J Anal Toxicol 1996
Test Studied
- Abbott Amphetamine Class and Amphetamine/Methamphetamine II FPIA
Diethylpropion
2 sources Siemens Healthineers. EMIT d.a.u. Amphetamine Class Assay. Instructions for use, revision…, 2024 Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
What It Found
- Siemens lists negative results with added diethylpropion in both amphetamine assays.
Keep in Mind
- The experiments tested the named parent drug.
- They do not address every metabolite or product.
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- The authors observed a urine response after Diethylpropion administration on the historical amphetamine class assay.
- The more selective Amphetamine/Methamphetamine II assay gave negative results for the group.
Keep in Mind
- The parent, a related metabolite or both may contribute.
- Signal strength, collection interval and the assay decision threshold matter.
Test Studied
- Abbott Amphetamine Class and Amphetamine/Methamphetamine II FPIA
Source Lin et al., Zhonghua Yi Xue Za Zhi (Taipei) 1991
What It Found
- A Taiwanese urine study specifically reported false-positive EMIT amphetamine reactions with Diethylpropion.
Keep in Mind
- Separate drug-only challenge concentrations and patient counts were not specified.
Test Studied
- Syva EMIT d.a.u. amphetamine screen
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Diethylpropion challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Siemens Healthineers. EMIT d.a.u. Amphetamine Class Assay. Instructions for use, revision…, 2024
Tests Studied
- EMIT d.a.u
- Amphetamine Class
Source Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
Test Studied
- EMIT II Plus Amphetamines
Doxepin
Source Merigian et al., Ann Emerg Med 1993
What It Found
- A 1993 case letter attributed a false-positive urine amphetamine result to doxepin.
Keep in Mind
- The case letter has no indexed abstract.
- Its title identifies the reported association, but the screening reagent, confirmation method and role of metabolites could not be verified.
Test Studied
- Historical urine amphetamine screen, reagent unverified
Source Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
What It Found
- In separate manufacturer testing, parent doxepin at 1,000 micrograms/mL gave negative results on EMIT II Plus at all three amphetamine cutoffs.
Keep in Mind
- The Siemens result applies to the parent compound on its own assay.
Test Studied
- Siemens EMIT II Plus Amphetamines, table 24
Ephedrine
3 sources D'Nicuola et al., J Anal Toxicol 1992 Stout et al., J Forensic Sci 2004 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- Ephedrine-related compounds reacted with some amphetamine reagents.
2 sources Stout et al., J Forensic Sci 2004 Sainz-Pastor et al., Scand J Clin Lab Invest 2026
What It Found
- A later GC-MS-checked emergency study also implicated ephedrine in unconfirmed amphetamine screens.
Source Caplan et al., Clin Chem 1987
What It Found
- The Abbott antibody showed very limited response to Ephedrine in the 1987 comparison.
Keep in Mind
- The abstract does not specify a Ephedrine concentration that crossed a screen cutoff.
Test Studied
- Abbott amphetamine/methamphetamine FPIA compared with Syva EMIT
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- The authors observed a urine response after Ephedrine administration on the historical amphetamine class assay.
- The more selective Amphetamine/Methamphetamine II assay gave negative results for the group.
Keep in Mind
- The parent, a related metabolite or both may contribute.
- Signal strength, collection interval and the assay decision threshold matter.
Test Studied
- Abbott Amphetamine Class and Amphetamine/Methamphetamine II FPIA
Source Armbruster et al., Clin Chem 1995
What It Found
- The authors identified ephedrine and pseudoephedrine as typical sympathomimetics among unconfirmed amphetamine specimens.
Keep in Mind
- This comparison did not attribute every individual discrepancy to one identified medicine or report a clinical probability.
Test Studied
- 1995 comparison of urine CEDIA, EMIT II, Roche RIA, OnLine and TDx screening
Source Boroda and Akhter, J Forensic Leg Med 2008
What It Found
- A child's urine screened positive after an ephedrine-containing cough mixture.
- Gas chromatography detected abundant ephedrine and excluded amphetamines.
Keep in Mind
- A single case cannot estimate the frequency of this result.
Test Studied
- Urine amphetamine dipstick with gas chromatography
Source Wilson and Smith, Ann Clin Biochem 1999
What It Found
- A UK external quality assessment included an authentic ephedrine-containing specimen (4 mg/L) and a separate mixture of 3.5 mg/L ephedrine with 1.5 mg/L phenylpropanolamine.
- Across the six amphetamine-interferent challenges, some laboratories reported amphetamine.
Keep in Mind
- The investigators pooled the error range across the challenges, which used different laboratory methods.
- It cannot establish a specific reagent or probability for a patient.
Test Studied
- UK NEQAS urine proficiency testing across multiple laboratories
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 3.1% relative response to Ephedrine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
2 sources D'Nicuola et al., J Anal Toxicol 1992 Sainz-Pastor et al., Scand J Clin Lab Invest 2026
Keep in Mind
- Performance depends on the compound, concentration and method.
3 sources D'Nicuola et al., J Anal Toxicol 1992 Stout et al., J Forensic Sci 2004 Sainz-Pastor et al., Scand J Clin Lab Invest 2026
Keep in Mind
- A class screen does not identify the individual drug.
4 sources D'Nicuola et al., J Anal Toxicol 1992 Stout et al., J Forensic Sci 2004 Sainz-Pastor et al., Scand J Clin Lab Invest 2026 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
Test Studied
- Syva EMIT, DRI Amphetamines and comparators
Etafedrine
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- The authors observed a urine response after Etafedrine administration on the historical amphetamine class assay.
- The more selective Amphetamine/Methamphetamine II assay gave negative results for the group.
Keep in Mind
- The parent, a related metabolite or both may contribute.
- Signal strength, collection interval and the assay decision threshold matter.
Test Studied
- Abbott Amphetamine Class and Amphetamine/Methamphetamine II FPIA
Fenfluramine
Source Ghawji et al., Ann Child Neurol Soc 2025
What It Found
- An unexpected amphetamine screen in a child treated for Dravet syndrome was negative for amphetamines by LC-MS, which identified fenfluramine.
Test Studied
- Clinical urine amphetamine immunoassay
Source Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
What It Found
- EMIT II Plus reacted to added fenfluramine.
Test Studied
- EMIT II Plus
Source FDA 510(k) K142353. First Sign Drug of Abuse Dip Card Test and Cup Test. Interference and…, 2014
What It Found
- The First Sign AMP 1000 did not show interference at 100 micrograms/mL.
Test Studied
- First Sign AMP 1000
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- Both assays showed reactivity with Fenfluramine in the authors’ stimulant study.
Keep in Mind
- This finding is specific to the historical reagents and administered products.
Test Studied
- Abbott Amphetamine Class and Amphetamine/Methamphetamine II FPIA
Source Lin et al., Zhonghua Yi Xue Za Zhi (Taipei) 1991
What It Found
- A Taiwanese urine study specifically reported false-positive EMIT amphetamine reactions with Fenfluramine.
Keep in Mind
- Separate drug-only challenge concentrations and patient counts were not specified.
Test Studied
- Syva EMIT d.a.u. amphetamine screen
3 sources Ghawji et al., Ann Child Neurol Soc 2025 Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024 FDA 510(k) K142353. First Sign Drug of Abuse Dip Card Test and Cup Test. Interference and…, 2014
Keep in Mind
- The clinical case and laboratory studies support a possible effect on some assays.
- A usual dose does not imply a positive result.
Mephentermine
2 sources Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024 Siemens Healthineers. EMIT d.a.u. Amphetamine Class Assay. Instructions for use, revision…, 2024
What It Found
- Siemens observed a positive response from mephentermine in both amphetamine assays.
Source Lin-Zhi International. LZI Amphetamines Enzyme Immunoassay for Hitachi 717. Instructions…, 2024
What It Found
- Lin-Zhi lists a negative result for mephentermine at 50 micrograms/mL on its test.
Test Studied
- LZI Amphetamines
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- Both assays showed reactivity with Mephentermine in the authors’ stimulant study.
Keep in Mind
- This finding is specific to the historical reagents and administered products.
Test Studied
- Abbott Amphetamine Class and Amphetamine/Methamphetamine II FPIA
3 sources Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024 Siemens Healthineers. EMIT d.a.u. Amphetamine Class Assay. Instructions for use, revision…, 2024 Lin-Zhi International. LZI Amphetamines Enzyme Immunoassay for Hitachi 717. Instructions…, 2024
Keep in Mind
- Keep mephentermine separate from phentermine.
- The response depends on the reagent and cutoff.
Source Siemens Healthineers. EMIT d.a.u. Amphetamine Class Assay. Instructions for use, revision…, 2024
Tests Studied
- Siemens EMIT d.a.u
- Amphetamine Class
Source Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
Test Studied
- EMIT II Plus
Metformin
Source Fucci, Forensic Sci Int 2012
What It Found
- An early report associated an unexpected result with metformin in a patient with diabetes.
Test Studied
- Clinical case
Source Pope et al., J Anal Toxicol 2023
What It Found
- In a later CEDIA experiment the parent drug did not trigger a positive even at 2,500 micrograms/mL.
Test Studied
- CEDIA Amphetamine/Ecstasy laboratory comparison
Both sources Fucci, Forensic Sci Int 2012 Pope et al., J Anal Toxicol 2023
Keep in Mind
- The single case and the spiking study do not establish a general effect of routine metformin use.
Methylphenidate
Source Manzi et al., Pediatr Emerg Care 2002
What It Found
- One older case report implicated methylphenidate.
Source Pope et al., J Anal Toxicol 2023
What It Found
- Very high concentrations of parent drug triggered CEDIA in spiked urine.
Keep in Mind
- The laboratory result does not establish that a usual methylphenidate dose will cause a positive.
Test Studied
- CEDIA Amphetamine/Ecstasy
Source Sainz-Pastor et al., Scand J Clin Lab Invest 2026
What It Found
- A later clinical study found no interference with methylphenidate in either method it evaluated.
Test Studied
- Clinical enzyme/lateral-flow comparison
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- Neither test identified the exposure to Methylphenidate in the authors’ stimulant dosing study.
Test Studied
- Two historical Abbott amphetamine fluorescence polarization immunoassays
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 0.31% for methylphenidate and 0.088% for ritalinic acid relative response.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
3 sources Manzi et al., Pediatr Emerg Care 2002 Pope et al., J Anal Toxicol 2023 Sainz-Pastor et al., Scand J Clin Lab Invest 2026
Keep in Mind
- Methylphenidate is distinct from prescription amphetamine.
2 sources Sainz-Pastor et al., Scand J Clin Lab Invest 2026 de la Torre et al., J Anal Toxicol 1996
Keep in Mind
- A negative result on these specific assays does not establish nonreactivity on all amphetamine tests.
Morazone
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- The authors observed a urine response after Morazone administration on the historical amphetamine class assay.
- The more selective Amphetamine/Methamphetamine II assay gave negative results for the group.
Keep in Mind
- The parent, a related metabolite or both may contribute.
- Signal strength, collection interval and the assay decision threshold matter.
Test Studied
- Abbott Amphetamine Class and Amphetamine/Methamphetamine II FPIA
Phendimetrazine
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- The authors observed a urine response after Phendimetrazine administration on the historical amphetamine class assay.
- The more selective Amphetamine/Methamphetamine II assay gave negative results for the group.
Keep in Mind
- The parent, a related metabolite or both may contribute.
- Signal strength, collection interval and the assay decision threshold matter.
Test Studied
- Abbott Amphetamine Class and Amphetamine/Methamphetamine II FPIA
Phenmetrazine
2 sources Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024 Siemens Healthineers. EMIT d.a.u. Amphetamine Class Assay. Instructions for use, revision…, 2024
What It Found
- Two Siemens assays reacted to phenmetrazine in urine.
Source Lin-Zhi International. LZI Amphetamines Enzyme Immunoassay for Hitachi 717. Instructions…, 2024
What It Found
- The Lin-Zhi assay listed a negative at 75 micrograms/mL.
Test Studied
- LZI Amphetamines
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- The authors observed a urine response after Phenmetrazine administration on the historical amphetamine class assay.
- The more selective Amphetamine/Methamphetamine II assay gave negative results for the group.
Keep in Mind
- The parent, a related metabolite or both may contribute.
- Signal strength, collection interval and the assay decision threshold matter.
Test Studied
- Abbott Amphetamine Class and Amphetamine/Methamphetamine II FPIA
3 sources Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024 Siemens Healthineers. EMIT d.a.u. Amphetamine Class Assay. Instructions for use, revision…, 2024 Lin-Zhi International. LZI Amphetamines Enzyme Immunoassay for Hitachi 717. Instructions…, 2024
Keep in Mind
- This finding is specific to phenmetrazine and the assays named.
Source Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
Test Studied
- EMIT II Plus
Source Siemens Healthineers. EMIT d.a.u. Amphetamine Class Assay. Instructions for use, revision…, 2024
Tests Studied
- EMIT d.a.u
- Amphetamine Class
Phenylpropanolamine
2 sources D'Nicuola et al., J Anal Toxicol 1992 Grinstead, Clin Chem 1989
What It Found
- High-concentration phenylpropanolamine standards reacted in an older EMIT urine study.
Keep in Mind
- Older laboratory findings do not establish interference at typical exposures.
Source D'Nicuola et al., J Anal Toxicol 1992
What It Found
- At 100 mg/L all the tested assays were negative.
Source Caplan et al., Clin Chem 1987
What It Found
- The Abbott antibody showed very limited response to Phenylpropanolamine in the 1987 comparison.
Keep in Mind
- The abstract does not specify a Phenylpropanolamine concentration that crossed a screen cutoff.
Test Studied
- Abbott amphetamine/methamphetamine FPIA compared with Syva EMIT
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- The authors observed a urine response after Phenylpropanolamine administration on the historical amphetamine class assay.
- The more selective Amphetamine/Methamphetamine II assay gave negative results for the group.
Keep in Mind
- The parent, a related metabolite or both may contribute.
- Signal strength, collection interval and the assay decision threshold matter.
Test Studied
- Abbott Amphetamine Class and Amphetamine/Methamphetamine II FPIA
Source Wilson and Smith, Ann Clin Biochem 1999
What It Found
- A UK external quality assessment included a mixture of 1.5 mg/L phenylpropanolamine with 3.5 mg/L ephedrine.
- Across the six amphetamine-interferent challenges, some laboratories reported amphetamine.
Keep in Mind
- The investigators pooled the error range across the challenges, which used different laboratory methods.
- It cannot establish a specific reagent or probability for a patient.
Test Studied
- UK NEQAS urine proficiency testing across multiple laboratories
Source Stout et al., J Forensic Sci 2004
Keep in Mind
- Other decongestants co-occurred in some clinical samples.
3 sources D'Nicuola et al., J Anal Toxicol 1992 Grinstead, Clin Chem 1989 Stout et al., J Forensic Sci 2004
Test Studied
- Syva EMIT and several comparator immunoassays
Pholedrine
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- Only the Amphetamine/Methamphetamine II reagent detected Pholedrine in the study.
Keep in Mind
- Responses can differ even between two assays from the same manufacturer.
Test Studied
- Abbott Amphetamine/Methamphetamine II and Amphetamine Class FPIA
Pseudoephedrine
Source Stout et al., J Forensic Sci 2004
What It Found
- Pseudoephedrine was present in 833 unconfirmed screens containing one or more of the decongestants examined in a military study.
2 sources Stout et al., J Forensic Sci 2004 D'Nicuola et al., J Anal Toxicol 1992
What It Found
- Fortified-urine experiments also demonstrated cross-reactivity on selected assays.
Keep in Mind
- These cohorts and concentrations do not establish how often a usual decongestant dose causes a positive.
Test Studied
- DRI Amphetamines, Abuscreen ONLINE and older EMIT reagents
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- The authors observed a urine response after Pseudoephedrine administration on the historical amphetamine class assay.
- The more selective Amphetamine/Methamphetamine II assay gave negative results for the group.
Keep in Mind
- The parent, a related metabolite or both may contribute.
- Signal strength, collection interval and the assay decision threshold matter.
Test Studied
- Abbott Amphetamine Class and Amphetamine/Methamphetamine II FPIA
Source DePriest et al., Pharmacotherapy 2013
What It Found
- A published letter specifically addresses pseudoephedrine-associated false-positive amphetamine immunoassay results.
Keep in Mind
- Its PubMed record has no abstract; assay-specific challenge findings come from the other cited studies.
Test Studied
- 2012 Pharmacotherapy correspondence on urine amphetamine immunoassays
Source Armbruster et al., Clin Chem 1995
What It Found
- The authors identified ephedrine and pseudoephedrine as typical sympathomimetics among unconfirmed amphetamine specimens.
Keep in Mind
- This comparison did not attribute every individual discrepancy to one identified medicine or report a clinical probability.
Test Studied
- 1995 comparison of urine CEDIA, EMIT II, Roche RIA, OnLine and TDx screening
Source Woodworth et al., Clin Chem 2006
What It Found
- Urine spiking confirmed a shallower dose-response curve for Pseudoephedrine than for amphetamine or methamphetamine.
Keep in Mind
- A dose-response slope cannot by itself rule out low concentrations of genuine amphetamine.
Test Studied
- Syva Emit II amphetamine/methamphetamine urine immunoassay
3 sources Stout et al., J Forensic Sci 2004 D'Nicuola et al., J Anal Toxicol 1992 de la Torre et al., J Anal Toxicol 1996
Keep in Mind
- Check the active ingredient on combination or similarly branded products.
Ranitidine
Source Poklis et al., J Anal Toxicol 1991
What It Found
- In an older study, 12 of 63 urine samples from 23 people taking ranitidine were false positive on monoclonal EMIT.
Keep in Mind
- Polyclonal EMIT and TDx II were negative in the first study.
Test Studied
- Monoclonal EMIT d.a.u. amphetamine/methamphetamine
Source Liu et al., Clin Chim Acta 2015
What It Found
- A later study reproduced interference on Beckman AMPH.
Keep in Mind
- Siemens EMIT II Plus was unaffected in the later experiment.
- Check the active ingredient on products bearing the Zantac name.
Test Studied
- Beckman Coulter AMPH
Source Dietzen et al., J Anal Toxicol 2001
What It Found
- A Veterans Affairs laboratory found that urine ranitidine above 43 µg/mL yielded a positive result on its Beckman Synchron assay.
Keep in Mind
- The platform and local population matter.
- The reported value is a urine concentration, not an oral dose.
Test Studied
- Beckman Synchron urine amphetamine assay
Tapentadol
Source Tang et al., Clin Toxicol (Phila) 2012
What It Found
- All 11 patients reporting recent immediate-release tapentadol use had negative urine amphetamine screens on Syva EMIT II.
Keep in Mind
- The clinical study enrolled patients taking 50–600 mg/day, relied on reported use and did not measure urinary tapentadol or its metabolites.
Test Studied
- Siemens Syva EMIT II amphetamine screen
Source Pope et al., J Anal Toxicol 2023
What It Found
- In a separate laboratory experiment, tapentadol added to urine at 400 micrograms/mL made the CEDIA amphetamine/ecstasy screen positive.
Keep in Mind
- The CEDIA experiment used a high urine concentration.
Test Studied
- CEDIA Amphetamine/Ecstasy (300 ng/mL cutoff)
Both sources Tang et al., Clin Toxicol (Phila) 2012 Pope et al., J Anal Toxicol 2023
Keep in Mind
- Neither finding establishes how often treatment causes a positive result across assays.
Vilazodone
Source Martinez-Brokaw et al., BMC Clin Pathol 2019
What It Found
- Two toddlers had unexpected positive amphetamine screens after accidental exposure.
- Neither vilazodone nor its M17 metabolite reproduced the finding on two assays up to 100 micrograms/mL.
Keep in Mind
- The tested parent drug and M17 metabolite have no demonstrated cross-reaction in these experiments.
Test Studied
- Two urine amphetamine immunoassays
Source Schlichting et al., J Emerg Med 2021
What It Found
- A separate toddler case had a positive Roche Amphetamines II screen with negative GC-MS confirmation.
Both sources Martinez-Brokaw et al., BMC Clin Pathol 2019 Schlichting et al., J Emerg Med 2021
Keep in Mind
- The cause of the toddler results remained unknown.
Khat
Source Toennes and Kauert, Clin Chem 2002
What It Found
- After four volunteers chewed khat leaves, some urine samples screened positive on the Mahsan amphetamine kit, while the Abbott assay stayed negative.
- GC-MS identified khat alkaloids.
Keep in Mind
- Khat contains several related compounds.
- A positive class screen does not identify the specific exposure.
Test Studied
- Mahsan-AMP(300) versus Abbott fluorescence polarization immunoassay
Promethazine
Source Melanson et al., Arch Pathol Lab Med 2006
What It Found
- Eight of 22 patients with detected promethazine had a false-positive result with one monoclonal reagent.
- Authors suspected a metabolite.
Keep in Mind
- Other reagents, including another EMIT II Plus amphetamines assay, did not show the same interference in a separate comparison.
Test Studied
- EMIT II Plus Monoclonal Amphetamine/Methamphetamine
2,5-Dimethoxyamphetamine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2,5-Dimethoxyamphetamine challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 30 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 10 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- 2,5-Dimethoxyamphetamine did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
2C-B
Source Kerrigan et al., J Anal Toxicol 2011
What It Found
- The tested series including 2C-B showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
Keep in Mind
- The tested reagents showed little recognition of these designer compounds despite structural similarity.
- Routine results cannot confirm or exclude the specific exposure.
Test Studied
- Commercial urine stimulant ELISAs tested against 2C, 2C-T and DO psychedelic phenethylamines
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2C-B challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 50 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 3 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
2C-I
Source Kerrigan et al., J Anal Toxicol 2011
What It Found
- The tested series including 2C-I showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
Keep in Mind
- The tested reagents showed little recognition of these designer compounds despite structural similarity.
- Routine results cannot confirm or exclude the specific exposure.
Test Studied
- Commercial urine stimulant ELISAs tested against 2C, 2C-T and DO psychedelic phenethylamines
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2C-I challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 50 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 2 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
2C-T
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2C-T challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 13 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- 2C-T did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
2C-T-2
Source Kerrigan et al., J Anal Toxicol 2011
What It Found
- The tested series including 2C-T-2 showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
Keep in Mind
- The tested reagents showed little recognition of these designer compounds despite structural similarity.
- Routine results cannot confirm or exclude the specific exposure.
Test Studied
- Commercial urine stimulant ELISAs tested against 2C, 2C-T and DO psychedelic phenethylamines
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2C-T-2 challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 35 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- 2C-T-2 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
2C-T-4
Source Kerrigan et al., J Anal Toxicol 2011
What It Found
- The tested series including 2C-T-4 showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
Keep in Mind
- The tested reagents showed little recognition of these designer compounds despite structural similarity.
- Routine results cannot confirm or exclude the specific exposure.
Test Studied
- Commercial urine stimulant ELISAs tested against 2C, 2C-T and DO psychedelic phenethylamines
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2C-T-4 challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 45 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
2C-T-7
Source Kerrigan et al., J Anal Toxicol 2011
What It Found
- The tested series including 2C-T-7 showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
Keep in Mind
- The tested reagents showed little recognition of these designer compounds despite structural similarity.
- Routine results cannot confirm or exclude the specific exposure.
Test Studied
- Commercial urine stimulant ELISAs tested against 2C, 2C-T and DO psychedelic phenethylamines
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2C-T-7 challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 100 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 9 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- 2C-T-7 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
3,4,5-Trimethoxyamphetamine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 3,4,5-Trimethoxyamphetamine challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 40 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- 3,4,5-Trimethoxyamphetamine did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
DOB
Source Kerrigan et al., J Anal Toxicol 2011
What It Found
- The tested series including DOB showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
Keep in Mind
- The tested reagents showed little recognition of these designer compounds despite structural similarity.
- Routine results cannot confirm or exclude the specific exposure.
Test Studied
- Commercial urine stimulant ELISAs tested against 2C, 2C-T and DO psychedelic phenethylamines
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the DOB challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 20 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 3 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
DOC
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the DOC challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 5 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 1 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- DOC did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
DOET
Source Kerrigan et al., J Anal Toxicol 2011
What It Found
- The tested series including DOET showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
Keep in Mind
- The tested reagents showed little recognition of these designer compounds despite structural similarity.
- Routine results cannot confirm or exclude the specific exposure.
Test Studied
- Commercial urine stimulant ELISAs tested against 2C, 2C-T and DO psychedelic phenethylamines
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the DOET challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 30 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 4.5 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- DOET did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
DOI
Source Kerrigan et al., J Anal Toxicol 2011
What It Found
- The tested series including DOI showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
Keep in Mind
- The tested reagents showed little recognition of these designer compounds despite structural similarity.
- Routine results cannot confirm or exclude the specific exposure.
Test Studied
- Commercial urine stimulant ELISAs tested against 2C, 2C-T and DO psychedelic phenethylamines
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the DOI challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 30 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 4 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- DOI did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
DOM
Source Kerrigan et al., J Anal Toxicol 2011
What It Found
- The tested series including DOM showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
Keep in Mind
- The tested reagents showed little recognition of these designer compounds despite structural similarity.
- Routine results cannot confirm or exclude the specific exposure.
Test Studied
- Commercial urine stimulant ELISAs tested against 2C, 2C-T and DO psychedelic phenethylamines
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the DOM challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 40 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 5.5 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Donepezil
Source Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
What It Found
- Siemens reports a measurable cutoff-equivalent response to donepezil.
Test Studied
- EMIT II Plus Amphetamines
Source Hughey and Colby, Clin Chem 2019
What It Found
- A separate study testing Abbott MULTIGENT did not reproduce a positive from added donepezil.
Test Studied
- Abbott MULTIGENT amphetamines
Both sources Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024 Hughey and Colby, Clin Chem 2019
Keep in Mind
- These studies demonstrate platform differences.
- Neither establishes how often a patient taking donepezil screens positive.
Flephedrone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Flephedrone challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 0.92% relative response to Flephedrone.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
Isoxsuprine
Source Siemens Healthineers. EMIT d.a.u. Amphetamine Class Assay. Instructions for use, revision…, 2024
What It Found
- Isoxsuprine is listed as reactive on the class reagent at 6 micrograms/mL.
Tests Studied
- EMIT d.a.u
- Amphetamine Class
Source Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
What It Found
- The II Plus test remained negative in the manufacturer’s comparison.
Test Studied
- EMIT II Plus Amphetamines
Both sources Siemens Healthineers. EMIT d.a.u. Amphetamine Class Assay. Instructions for use, revision…, 2024 Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
Keep in Mind
- Whether the test was the EMIT class or the II Plus reagent changes the interpretation.
Meta-chlorophenylpiperazine
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Meta-chlorophenylpiperazine spike of 5,600 ng/mL, the mean assay response was 528 ng/mL equivalent (9.4% cross-reactivity), above the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Meta-chlorophenylpiperazine challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 7 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 26% relative response to Meta-chlorophenylpiperazine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
Methcathinone
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 75,000 ng/mL for Methcathinone on the Biosite Triage screen.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Biosite Triage Amphetamines screen, Krasowski et al. supplement, A
- AMPH, row 23
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Methcathinone challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Nylidrin
Source Siemens Healthineers. EMIT d.a.u. Amphetamine Class Assay. Instructions for use, revision…, 2024
What It Found
- The class reagent lists a positive response at 2 micrograms/mL.
Tests Studied
- EMIT d.a.u
- Amphetamine Class
Source Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
What It Found
- The II Plus instructions list a negative result at 750 micrograms/mL.
Test Studied
- EMIT II Plus Amphetamines
Both sources Siemens Healthineers. EMIT d.a.u. Amphetamine Class Assay. Instructions for use, revision…, 2024 Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
Keep in Mind
- The two sets of instructions describe different assays from the same manufacturer.
Phenelzine
Source Siemens Healthineers. EMIT d.a.u. Amphetamine Class Assay. Instructions for use, revision…, 2024
What It Found
- The class-assay instructions name phenelzine as a possible source of a positive.
Keep in Mind
- The class instructions do not provide a case series, frequency or concentration for phenelzine.
Tests Studied
- EMIT d.a.u
- Amphetamine Class
Source Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
What It Found
- The II Plus specificity study lists the parent compound as negative at the concentrations tested.
Test Studied
- EMIT II Plus Amphetamines
Phenethylamine
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 50,000 ng/mL for Phenethylamine on the Biosite Triage screen.
- At least one other reagent in the same table showed no reaction.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Biosite Triage Amphetamines screen, Krasowski et al. supplement, A
- AMPH, row 24
Source Parsons et al., Clin Chem 1993
What It Found
- Phenethylamine produced a positive amphetamine line when added to drug-free urine at 100 mg/L.
Keep in Mind
- This was a high-concentration challenge with an early device, without a patient dosing study.
Test Studied
- Abbott Advisor multianalyte urine panel
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 7.6% relative response to Phenethylamine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
Propranolol
Source Marin et al., J Anal Toxicol 2016
What It Found
- Propranolol triggered EMIT II Plus in fortified urine at 41 micrograms/mL.
Test Studied
- Syva EMIT II Plus Amphetamines
Source Pope et al., J Anal Toxicol 2023
What It Found
- Another group reported a negative CEDIA result with a much higher parent-drug concentration.
Test Studied
- CEDIA Amphetamine/Ecstasy
Both sources Marin et al., J Anal Toxicol 2016 Pope et al., J Anal Toxicol 2023
Keep in Mind
- These experiments used different reagents.
- The likelihood at therapeutic doses remains unclear.
Propylhexedrine
Source Oellerich et al., J Clin Chem Clin Biochem 1977
What It Found
- An early EMIT study demonstrated reactivity with propylhexedrine hydrochloride in urine.
Source Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
What It Found
- The II Plus instructions list negative results for the concentrations used on that newer reagent.
Test Studied
- EMIT II Plus Amphetamines
All 3 sources Oellerich et al., J Clin Chem Clin Biochem 1977 Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
Keep in Mind
- This ingredient differs from levmetamfetamine.
- Laboratory findings do not establish a rate after correctly used inhalers.
2 sources Oellerich et al., J Clin Chem Clin Biochem 1977 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
Test Studied
- Historical EMIT amphetamine
Trimethobenzamide
Source Jones et al., Clin Chem 1993
What It Found
- A laboratory letter documented interference on older reagents.
Test Studied
- Historical amphetamine/methamphetamine immunoassays
Source Interference of Selected Clinical Medicines on DRI and TDx Immunoassays of Morphine and…, 1999
What It Found
- A separate DRI methamphetamine-calibrated assay reacted strongly in fortified urine.
Keep in Mind
- The DRI response came from high-concentration fortified urine.
Test Studied
- DRI
Source Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
What It Found
- EMIT II Plus was negative with parent trimethobenzamide at 500 micrograms/mL.
Test Studied
- EMIT II Plus Amphetamines
All 3 sources Jones et al., Clin Chem 1993 Interference of Selected Clinical Medicines on DRI and TDx Immunoassays of Morphine and…, 1999 Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
Keep in Mind
- Assays with similar names can give different results.
A Related Drug the Test Picks Up
4-Fluoroamphetamine
Source Beck et al., Drug Test Anal 2014
What It Found
- At a 4-fluoroamphetamine spike of 6,300 ng/mL, the mean assay response was 469 ng/mL equivalent (7.4% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Röhrich et al., Forensic Sci Int 2012
What It Found
- Two subjects' urine initially screened positive for amphetamines and contained 4-fluoroamphetamine, with no other drugs detected.
- The authors measured about 6% cross-reactivity.
Keep in Mind
- The study concerned a structurally related recreational stimulant.
Test Studied
- CEDIA DAU Amphetamines with GC-MS
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-Fluoroamphetamine challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 15 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 2.95 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 54% relative response to 4-Fluoroamphetamine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
MDA
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 2,500 ng/mL for MDA on the Abbott Architect screen.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Abbott Architect Amphetamines screen, Krasowski et al. supplement, A
- AMPH, row 14
Source Ward et al., J Forensic Sci 1994
What It Found
- In fortified urine the dual-target RIA recognized MDMA at 77% relative cross-reactivity and MDA at greater than 100%.
Keep in Mind
- The assay was developed for d-amphetamine and d-methamphetamine; this response depends on its particular antibodies.
Test Studied
- Dual amphetamine/methamphetamine radioimmunoassay using two sheep antisera
Source Poklis et al., Forensic Sci Int 1993
What It Found
- Racemic MDA had an approximate threshold of 800 ng/mL and racemic MDMA about 3,000 ng/mL on this reagent.
Keep in Mind
- The assays favored the S isomers; the separate dosing experiment used rats.
Test Studied
- EMIT d.a.u. monoclonal amphetamine/methamphetamine assay
Source Hsu et al., J Anal Toxicol 2003
What It Found
- Fortified urines and case specimens showed that the ability to detect methylenedioxy stimulants varies by assay.
Keep in Mind
- The intended target group and cutoff must be checked before interpreting an amphetamine-class result.
Test Studied
- Eight marketed stimulant immunoassays, including CEDIA Amphetamines/Ecstasy and Abuscreen OnLine HS Amphetamine/MDMA
2 sources Hsu et al., J Anal Toxicol 2003 Loor et al., J Anal Toxicol 2002
What It Found
- Several combination assays intentionally include these compounds.
Source Ruangyuttikarn and Moody, J Anal Toxicol 1988
What It Found
- A fortified-urine study found measurable recognition of MDA on all three amphetamine assays, with different responses by reagent.
Keep in Mind
- The range tested extended to very high levels.
- A class screen cannot identify a particular analogue.
Test Studied
- Abuscreen RIA, Syva EMIT and Abbott TDx FPIA
Source Loor et al., J Anal Toxicol 2002
What It Found
- The combined screen recognized MDA at 113% relative reactivity.
Keep in Mind
- This multiplex is designed to recognize several amphetamine-type drugs and cannot identify which one is present.
Test Studied
- CEDIA Amphetamines/Ecstasy multiplex at 500 or 1,000 ng/mL
Source Apollonio et al., J Anal Toxicol 2007
What It Found
- In a comparison with 50 ng/mL target standards, the assay's relative response to MDA was 282%.
Keep in Mind
- The authors evaluated urine separately as a specimen matrix.
- The standard comparison does not show an individual post-dose positive.
Test Studied
- Bio-Quant Direct ELISA for amphetamines
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 110% relative response to MDA.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
MDMA
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 1,300 ng/mL for MDMA on the Abbott Architect screen.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Abbott Architect Amphetamines screen, Krasowski et al. supplement, A
- AMPH, row 15
Source Kunsman et al., J Anal Toxicol 1990
What It Found
- Fortified urine containing MDMA reacted with Abbott TDx.
- In the tested concentration series the Syva assay became positive only at 10 µg/mL.
Keep in Mind
- A class-screen response does not identify the individual stimulant.
Test Studied
- Abbott TDx and Syva EMIT d.a.u. amphetamine immunoassays
Source Ward et al., J Forensic Sci 1994
What It Found
- In fortified urine the dual-target RIA recognized MDMA at 77% relative cross-reactivity and MDA at greater than 100%.
Keep in Mind
- The assay was developed for d-amphetamine and d-methamphetamine; this response depends on its particular antibodies.
Test Studied
- Dual amphetamine/methamphetamine radioimmunoassay using two sheep antisera
Source Poklis et al., Forensic Sci Int 1993
What It Found
- Racemic MDA had an approximate threshold of 800 ng/mL and racemic MDMA about 3,000 ng/mL on this reagent.
Keep in Mind
- The assays favored the S isomers; the separate dosing experiment used rats.
Test Studied
- EMIT d.a.u. monoclonal amphetamine/methamphetamine assay
Source Hsu et al., J Anal Toxicol 2003
What It Found
- Fortified urines and case specimens showed that the ability to detect methylenedioxy stimulants varies by assay.
Keep in Mind
- The intended target group and cutoff must be checked before interpreting an amphetamine-class result.
Test Studied
- Eight marketed stimulant immunoassays, including CEDIA Amphetamines/Ecstasy and Abuscreen OnLine HS Amphetamine/MDMA
2 sources Hsu et al., J Anal Toxicol 2003 Loor et al., J Anal Toxicol 2002
What It Found
- Several combination assays intentionally include these compounds.
Source Ruangyuttikarn and Moody, J Anal Toxicol 1988
What It Found
- A fortified-urine study found measurable recognition of MDMA on all three amphetamine assays, with different responses by reagent.
Keep in Mind
- The range tested extended to very high levels.
- A class screen cannot identify a particular analogue.
Test Studied
- Abuscreen RIA, Syva EMIT and Abbott TDx FPIA
Source Loor et al., J Anal Toxicol 2002
What It Found
- The combined screen recognized MDMA at 199% relative reactivity.
Keep in Mind
- This multiplex is designed to recognize several amphetamine-type drugs and cannot identify which one is present.
Test Studied
- CEDIA Amphetamines/Ecstasy multiplex at 500 or 1,000 ng/mL
Source Crouch et al., J Anal Toxicol 2002
What It Found
- MDMA was identified in many urine samples that screened positive for amphetamines when the definitive test panel was expanded.
Keep in Mind
- The percentage varied by device and the selected population.
Test Studied
- Five on-site urine drug devices in an 800-person DUI field study
Source Woodworth et al., Clin Chem 2006
What It Found
- Urine spiking confirmed a shallower dose-response curve for MDMA than for amphetamine or methamphetamine.
Keep in Mind
- A dose-response slope cannot by itself rule out low concentrations of genuine amphetamine.
Test Studied
- Syva Emit II amphetamine/methamphetamine urine immunoassay
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 130% relative response to MDMA.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
N-Ethyl-4-methoxyamphetamine
Source Marson et al., J Anal Toxicol 2000
What It Found
- An authentic urine containing N-ethyl-4-methoxyamphetamine was positive by FPIA and negative by Triage 8.
- Investigators identified the analogue using a synthesized reference.
Keep in Mind
- The two assays used different cutoffs and this was one clinical specimen.
Test Studied
- Urine amphetamines FPIA at 300 ng/mL and Triage 8 at 1,000 ng/mL
2-Aminoindane
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2-Aminoindane challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
2-fluoroamphetamine
Source Beck et al., Drug Test Anal 2014
What It Found
- At a 2-fluoroamphetamine spike of 4,900 ng/mL, the mean assay response was 467 ng/mL equivalent (9.5% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 32% relative response to 2-fluoroamphetamine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
2-fluoromethamphetamine
Source Beck et al., Drug Test Anal 2014
What It Found
- At a 2-fluoromethamphetamine spike of 2,600 ng/mL, the mean assay response was 489 ng/mL equivalent (19% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 13% relative response to 2-fluoromethamphetamine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
2C-C
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2C-C challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 80 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 5 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
2C-E
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2C-E challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 45 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
3 fluoroamphetamine
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 32% relative response to 3 fluoroamphetamine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
3 methylmethcathinone
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 3.7% relative response to 3 methylmethcathinone.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
3-fluoromethamphetamine
Source Beck et al., Drug Test Anal 2014
What It Found
- At a 3-fluoromethamphetamine spike of 800 ng/mL, the mean assay response was 461 ng/mL equivalent (58% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 77% relative response to 3-fluoromethamphetamine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
3-Trifluoromethylphenylpiperazine
Source Beck et al., Drug Test Anal 2014
What It Found
- At a TFMPP (3-trifluoromethylphenylpiperazine) spike of 5,500 ng/mL, the mean assay response was 422 ng/mL equivalent (7.7% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 3-TFMPP challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 7 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
4 ethylmethcathinone
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 5.6% relative response to 4 ethylmethcathinone.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
4 methylbuphedrone
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 10% relative response to 4 methylbuphedrone.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
4-CAP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-CAP challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 5 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 9 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
4-EEC
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-EEC challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 60 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
4-Fluoromethamphetamine
Source Beck et al., Drug Test Anal 2014
What It Found
- At a 4-fluoromethamphetamine spike of 700 ng/mL, the mean assay response was 557 ng/mL equivalent (80% cross-reactivity), above the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-Fluoromethamphetamine challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 1.5 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 2.5 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 92% relative response to 4-Fluoromethamphetamine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
4-MEC
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-MEC challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 80 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 37 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 4.8% relative response to 4-MEC.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
4-Methylamphetamine
Source Beck et al., Drug Test Anal 2014
What It Found
- At a 4-methylamphetamine spike of 9,000 ng/mL, the mean assay response was 498 ng/mL equivalent (5.5% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-Methylamphetamine challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 9 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 7 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
4-Methylthioamphetamine
Source Kerrigan et al., J Anal Toxicol 2011
What It Found
- Added 4-methylthioamphetamine showed 25% and 200% relative reactivity on the two amphetamine-directed reagents tested.
Keep in Mind
- The measurements vary by antibody and do not give a patient-level likelihood.
Test Studied
- Two amphetamine-directed urine ELISAs in a nine-assay study
Source Apollonio et al., J Anal Toxicol 2007
What It Found
- In a comparison with 50 ng/mL target standards, the assay's relative response to 4-Methylthioamphetamine was 280%.
Keep in Mind
- The authors evaluated urine separately as a specimen matrix.
- The standard comparison does not show an individual post-dose positive.
Test Studied
- Bio-Quant Direct ELISA for amphetamines
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-Methylthioamphetamine challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 2 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 5 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
4-TFMPP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-TFMPP challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 90 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
5-APB
Source Beck et al., Drug Test Anal 2014
What It Found
- At a 5-APB spike of 1,600 ng/mL, the mean assay response was 490 ng/mL equivalent (31% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-APB challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 2 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 2 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 87% relative response to 5-APB.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
5-APDB
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-APDB challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 1 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 0.2 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
5-APDI
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-APDI challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 3 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 3 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
5-IAI
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-IAI challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 40 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 4 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
5-IT
Source Beck et al., Drug Test Anal 2014
What It Found
- At a 5-IT spike of 6,300 ng/mL, the mean assay response was 484 ng/mL equivalent (7.7% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-IT challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 10 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 30 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 36% relative response to 5-IT.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
5-MeO-AMT
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-MeO-AMT challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 40 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 6 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
5-MeO-MiPT
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-MeO-MiPT challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 40 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
6-APB
Source Beck et al., Drug Test Anal 2014
What It Found
- At a 6-APB spike of 3,700 ng/mL, the mean assay response was 454 ng/mL equivalent (12% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 6-APB challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 5 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 8.5 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 150% relative response to 6-APB.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
Alpha-methyltryptamine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Alpha-methyltryptamine challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 20 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 2.5 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
BDB
Source Loor et al., J Anal Toxicol 2002
What It Found
- The combined screen recognized BDB at 72% relative reactivity.
Keep in Mind
- This multiplex is designed to recognize several amphetamine-type drugs and cannot identify which one is present.
Test Studied
- CEDIA Amphetamines/Ecstasy multiplex at 500 or 1,000 ng/mL
Benzedrone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Benzedrone challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 75 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Benzylpiperazine
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Benzylpiperazine spike of 15,800 ng/mL, the mean assay response was 339 ng/mL equivalent (2.1% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Benzylpiperazine challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 25 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Bromo-DragonFLY
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Bromo-DragonFLY challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 0.8 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Buphedrone
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Buphedrone spike of 14,400 ng/mL, the mean assay response was 487 ng/mL equivalent (3.4% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Buphedrone challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 30 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Butylone
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Butylone spike of 8,700 ng/mL, the mean assay response was 436 ng/mL equivalent (5.0% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Butylone challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 15 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Dibenzylpiperazine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Dibenzylpiperazine challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 80 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Dimethocaine
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Dimethocaine spike of 10,900 ng/mL, the mean assay response was 456 ng/mL equivalent (4.2% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Dimethylone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Dimethylone challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Dimethyltryptamine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Dimethyltryptamine challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 40 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Dipropyltryptamine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Dipropyltryptamine challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 30 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Ethcathinone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Ethcathinone challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 100 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Ethylamphetamine
Source Smith and Kidwell, Forensic Sci Int 1991
What It Found
- The N-ethyl analogue of amphetamine produced measurable antibody reactivity in a urine isomer challenge.
Keep in Mind
- The abstract does not specify an individual test cutoff or establish a positive result after prescribed use.
Test Studied
- Historical commercial amphetamine/methamphetamine urine immunoassays
Ethylone
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Ethylone spike of 16,000 ng/mL, the mean assay response was 448 ng/mL equivalent (2.8% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Ethylone challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 30 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 7.2% relative response to Ethylone.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
Eutylone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Eutylone challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 10 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
MBDB
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 10,000 ng/mL for MBDB on the Biosite Triage screen.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Biosite Triage Amphetamines screen, Krasowski et al. supplement, A
- AMPH, row 17
Source Loor et al., J Anal Toxicol 2002
What It Found
- The combined screen recognized MBDB at 123% relative reactivity.
Keep in Mind
- This multiplex is designed to recognize several amphetamine-type drugs and cannot identify which one is present.
Test Studied
- CEDIA Amphetamines/Ecstasy multiplex at 500 or 1,000 ng/mL
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 68% relative response to MBDB.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
MDAI
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the MDAI challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 75 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 40 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
MDEA
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 8,000 ng/mL for MDEA on the Abbott AxSYM screen.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Abbott AxSYM Amphetamines screen, Krasowski et al. supplement, A
- AMPH, row 16
Source Kunsman et al., J Anal Toxicol 1990
What It Found
- Fortified urine containing MDEA reacted with Abbott TDx.
- In the tested concentration series the Syva assay became positive only at 10 µg/mL.
Keep in Mind
- A class-screen response does not identify the individual stimulant.
Test Studied
- Abbott TDx and Syva EMIT d.a.u. amphetamine immunoassays
Source Ruangyuttikarn and Moody, J Anal Toxicol 1988
What It Found
- A fortified-urine study found measurable recognition of MDEA on all three amphetamine assays, with different responses by reagent.
Keep in Mind
- The range tested extended to very high levels.
- A class screen cannot identify a particular analogue.
Test Studied
- Abuscreen RIA, Syva EMIT and Abbott TDx FPIA
Source Loor et al., J Anal Toxicol 2002
What It Found
- The combined screen recognized MDEA at 207% relative reactivity.
Keep in Mind
- This multiplex is designed to recognize several amphetamine-type drugs and cannot identify which one is present.
Test Studied
- CEDIA Amphetamines/Ecstasy multiplex at 500 or 1,000 ng/mL
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the MDEA challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 0.25 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 5 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 43% relative response to MDEA.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
MDPBP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the MDPBP challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 40 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
MDPPP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the MDPPP challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 30 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Mephedrone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Mephedrone challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 80 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 10% relative response to Mephedrone.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
Methedrone
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Methedrone spike of 24,600 ng/mL, the mean assay response was 453 ng/mL equivalent (1.8% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Methedrone challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 40 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 2% relative response to Methedrone.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
Methiopropamine
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Methiopropamine spike of 2,100 ng/mL, the mean assay response was 267 ng/mL equivalent (13% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Methiopropamine challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 4 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 0.9 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 1.7% relative response to Methiopropamine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
Methylenedioxypyrovalerone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Methylenedioxypyrovalerone challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 3.5% relative response to Methylenedioxypyrovalerone.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
Methylone
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Methylone spike of 20,300 ng/mL, the mean assay response was 514 ng/mL equivalent (2.5% cross-reactivity), above the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Methylone challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 40 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 4% relative response to Methylone.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
MOPPP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the MOPPP challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 40 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
N ethylbuphedrone
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 5.4% relative response to N ethylbuphedrone.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
Naphyrone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Naphyrone challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 70 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Para-fluorophenylpiperazine
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Para-fluorophenylpiperazine spike of 16,700 ng/mL, the mean assay response was 488 ng/mL equivalent (2.9% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Pentedrone
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Pentedrone spike of 14,000 ng/mL, the mean assay response was 496 ng/mL equivalent (3.5% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Pentedrone challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 30 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Pentylone
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Pentylone spike of 7,900 ng/mL, the mean assay response was 475 ng/mL equivalent (6.0% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Pentylone challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 10 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 7.6% relative response to Pentylone.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
PMA
Source Loor et al., J Anal Toxicol 2002
What It Found
- The combined screen recognized PMA at 24% relative reactivity.
Keep in Mind
- This multiplex is designed to recognize several amphetamine-type drugs and cannot identify which one is present.
Test Studied
- CEDIA Amphetamines/Ecstasy multiplex at 500 or 1,000 ng/mL
Source Apollonio et al., J Anal Toxicol 2007
What It Found
- In a comparison with 50 ng/mL target standards, the assay's relative response to PMA was 265%.
Keep in Mind
- The authors evaluated urine separately as a specimen matrix.
- The standard comparison does not show an individual post-dose positive.
Test Studied
- Bio-Quant Direct ELISA for amphetamines
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the PMA challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 4 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 7 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Para-methoxyamphetamine spike of 2,200 ng/mL, the mean assay response was 393 ng/mL equivalent (18% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
PMMA
Source Loor et al., J Anal Toxicol 2002
What It Found
- The combined screen recognized PMMA at 100% relative reactivity.
Keep in Mind
- This multiplex is designed to recognize several amphetamine-type drugs and cannot identify which one is present.
Test Studied
- CEDIA Amphetamines/Ecstasy multiplex at 500 or 1,000 ng/mL
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the PMMA challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 0.9 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 10 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Para-methoxymethamphetamine spike of 350 ng/mL, the mean assay response was 394 ng/mL equivalent (113% cross-reactivity), below the 500 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Amphetamine/Ecstasy urine assay, cutoff 500 ng/mL
The Test Is Made to Find It
Amphetaminil
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- After Amphetaminil administration the investigators detected amphetamine formed by metabolism in urine.
Keep in Mind
- Controlled excretion data come from historical stimulant preparations and a limited number of subjects.
Test Studied
- Two Abbott fluorescence polarization amphetamine assays and chromatographic testing after stimulant administration
Clobenzorex
Source Valtier and Cody, J Forensic Sci 1999
What It Found
- A controlled study identified d-amphetamine in urine after clobenzorex administration.
Test Studied
- Urine GC-MS with enantiomer analysis
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- After Clobenzorex administration the investigators detected amphetamine formed by metabolism in urine.
Keep in Mind
- Controlled excretion data come from historical stimulant preparations and a limited number of subjects.
Test Studied
- Two Abbott fluorescence polarization amphetamine assays and chromatographic testing after stimulant administration
Source Maurer et al., J Chromatogr B Biomed Sci Appl 1997
What It Found
- After 60 mg clobenzorex the authors attributed the positive TDx results to genuine amphetamine in urine.
- The parent drug did not cross-react on that reagent.
Keep in Mind
- This experiment used a particular dose and assay.
Test Studied
- Abbott TDx (meth)amphetamine II and GC-MS
All 3 sources Valtier and Cody, J Forensic Sci 1999 de la Torre et al., J Anal Toxicol 1996 Maurer et al., J Chromatogr B Biomed Sci Appl 1997
Keep in Mind
- This is an actual metabolite.
- Product availability depends on country.
Dimethylamphetamine
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- After Dimethylamphetamine administration the investigators detected amphetamine formed by metabolism in urine.
Keep in Mind
- Controlled excretion data come from historical stimulant preparations and a limited number of subjects.
Test Studied
- Two Abbott fluorescence polarization amphetamine assays and chromatographic testing after stimulant administration
Fenetylline
Source Yoshimura et al., Xenobiotica 1988
What It Found
- Researchers measured actual amphetamine in human urine after fenetylline administration.
Keep in Mind
- The finding applies to documented fenetylline exposure.
Test Studied
- Urine GC and HPLC studies
Source Oellerich et al., J Clin Chem Clin Biochem 1977
What It Found
- An older spiking experiment also demonstrated EMIT reactivity with parent fenetylline.
Test Studied
- Historical EMIT amphetamine
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- After Fenetylline administration the investigators detected amphetamine formed by metabolism in urine.
Keep in Mind
- Controlled excretion data come from historical stimulant preparations and a limited number of subjects.
Test Studied
- Two Abbott fluorescence polarization amphetamine assays and chromatographic testing after stimulant administration
2 sources Yoshimura et al., Xenobiotica 1988 Oellerich et al., J Clin Chem Clin Biochem 1977
Keep in Mind
- A product name alone does not establish its ingredients.
Fenproporex
Source Cody et al., J Anal Toxicol 1999
What It Found
- After fenproporex administration, researchers detected amphetamine in urine, including both enantiomers.
Keep in Mind
- An amphetamine result can reflect metabolism of this ingredient.
- Product availability depends on country.
Test Studied
- Urine GC-MS after multidose administration
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- After Fenproporex administration the investigators detected amphetamine formed by metabolism in urine.
Keep in Mind
- Controlled excretion data come from historical stimulant preparations and a limited number of subjects.
Test Studied
- Two Abbott fluorescence polarization amphetamine assays and chromatographic testing after stimulant administration
Levomethamphetamine
4 sources Smith et al., J Anal Toxicol 2014 Poklis and Moore, Ther Drug Monit 1995 Poklis and Moore, J Toxicol Clin Toxicol 1995 Poklis et al., J Anal Toxicol 1993
What It Found
- The nasal inhalers studied contained l-methamphetamine.
Keep in Mind
- The tests, cutoffs and inhaler formulations matter.
Source Poklis and Moore, Ther Drug Monit 1995
What It Found
- In one six-person study, some urine samples were positive on an EMIT amphetamine class screen while every sample was negative on the monoclonal assay.
Test Studied
- Urine EMIT class and monoclonal assays
Source Poklis et al., J Anal Toxicol 1993
What It Found
- Another study found all seven participants’ samples negative on EMIT II at its 1,000 ng/mL cutoff.
Test Studied
- EMIT II
Source Ward et al., J Forensic Sci 1994
What It Found
- Levomethamphetamine showed 2.4% relative cross-reactivity; the antibody’s response was much stronger to d-methamphetamine.
Keep in Mind
- This bench measurement cannot predict the result on a contemporary test after using an inhaler.
Test Studied
- Historical dual amphetamine/methamphetamine RIA
2 sources Smith et al., J Anal Toxicol 2014 Poklis and Moore, J Toxicol Clin Toxicol 1995
Keep in Mind
- An amphetamine-class screen cannot tell the d- and l-forms apart.
Source Smith et al., J Anal Toxicol 2014
Keep in Mind
- Check the actual active ingredient on the product.
Test Studied
- EMIT II Plus
Mefenorex
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- After Mefenorex administration the investigators detected amphetamine formed by metabolism in urine.
Keep in Mind
- Controlled excretion data come from historical stimulant preparations and a limited number of subjects.
Test Studied
- Two Abbott fluorescence polarization amphetamine assays and chromatographic testing after stimulant administration
Amphetamine/dextroamphetamine mixed salts
Both sources Cody et al., J Anal Toxicol 2003 Cody et al., J Anal Toxicol 2004
What It Found
- Prescribed mixed salts contain amphetamine.
- Some samples with at least 500 ng/mL by confirmation remained immunoassay-negative.
Keep in Mind
- Screening cutoffs and the response to individual isomers influence whether a particular specimen tests positive.
Source Cody et al., J Anal Toxicol 2003
What It Found
- After controlled administration, GC-MS identified amphetamine in urine.
Test Studied
- Urine immunoassay and GC-MS after mixed amphetamine salts
Source Cody et al., J Anal Toxicol 2004
What It Found
- After five daily 20 mg doses, urine contained genuine amphetamine.
Keep in Mind
- Five participants took the studied formulation.
- Enantiomer responses and individual urine concentrations differed.
Test Studied
- Repeated Adderall dosing with urine amphetamine/enantiomer measurement and immunoassay
Benzphetamine
Source Cody and Valtier, J Anal Toxicol 1998
What It Found
- After benzphetamine administration, d-amphetamine was found as a metabolite.
- Some participants remained below the study cutoff.
Keep in Mind
- A real metabolite can explain an unexpected definitive result.
Test Studied
- Urine GC-MS with enantiomer analysis
Dextroamphetamine
Both sources Poklis et al., J Anal Toxicol 1998 Helland et al., J Anal Toxicol 2025
What It Found
- Dextroamphetamine is the d-isomer of amphetamine.
- Controlled oral doses produced measurable urinary amphetamine.
Source Poklis et al., J Anal Toxicol 1998
Keep in Mind
- Lower therapeutic doses did not always exceed the screening cutoffs examined.
Test Studied
- TDx, EMIT d.a.u., EMIT II and GC-MS
Famprofazone
Source Cody, Forensic Sci Int 1996
What It Found
- A volunteer study measured both amphetamine isomers after famprofazone.
Keep in Mind
- A small metabolism study establishes a possible source, not a detection probability.
- Product availability depends on country.
Test Studied
- Urine enantiomer analysis after oral administration
Lisdexamfetamine
Both sources Comiran et al., Biopharm Drug Dispos 2021 Chermá et al., J Anal Toxicol 2022
What It Found
- Lisdexamfetamine is converted into d-amphetamine.
- Studies in treated patients and controlled administration detected amphetamine in urine.
Keep in Mind
- The result can reflect the prescribed medicine.
- Detection varies with the test and specimen.
Test Studied
- Urine quantitative and enantiomer-specific testing
Methamphetamine
Source Kim et al., Ther Drug Monit 2004
What It Found
- Amphetamine is a metabolite of methamphetamine.
- Both were measured after supervised oral methamphetamine administration.
Keep in Mind
- A medication and laboratory review can put a definitive result in context.
Test Studied
- GC-MS after controlled oral methamphetamine
Selegiline
Both sources Shin, Drug Metab Dispos 1997 Ramseier et al., Electrophoresis 1999
What It Found
- Selegiline can produce l-amphetamine and l-methamphetamine.
Keep in Mind
- A laboratory may need enantiomer-specific testing.
Source Shin, Drug Metab Dispos 1997
What It Found
- Human metabolic studies identified both in urine.
Keep in Mind
- The cited work does not establish identical detection across all routes and doses.
Test Studied
- Isomer-specific analysis after human selegiline administration
Source Ramseier et al., Electrophoresis 1999
What It Found
- A patient taking selegiline had R-amphetamine and R-methamphetamine identified in urine by enantiomer-specific analysis.
Keep in Mind
- This finding demonstrates genuine metabolites.
- It does not define a screening cutoff.
Test Studied
- Urine chiral capillary electrophoresis
Suspected, but Not Proven
Desipramine
Source Merigian and Browning, Ann Emerg Med 1993
What It Found
- An older case report names both amantadine and desipramine.
Keep in Mind
- The case does not establish independent desipramine causation.
Test Studied
- Historical case, reagent unverified
Source Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
What It Found
- EMIT II Plus parent-drug studies gave negative results for desipramine at concentrations of 300 to 800 micrograms/mL, depending on cutoff.
Keep in Mind
- The manufacturer tested a specific reagent and the parent drug.
Test Studied
- EMIT II Plus Amphetamines
Fluoxetine
Source Marin et al., J Anal Toxicol 2016
What It Found
- Fluoxetine was co-detected in some unconfirmed screens, but the independent fortified-urine study did not list it among AMP-positive standards.
Source Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
What It Found
- Siemens reports a negative result for parent fluoxetine at 500 micrograms/mL across three cutoffs.
Keep in Mind
- The negative parent-drug experiment applies to the reagent tested.
Source Savoca et al., Clin Chem Lab Med 2004
What It Found
- A Swiss laboratory also identified fluoxetine in discordant AxSYM specimens.
- The authors described it as a previously reported cross-reactant.
- They did not demonstrate that it caused an individual result.
Test Studied
- Abbott AxSYM Amphetamine/Methamphetamine II FPIA
2 sources Marin et al., J Anal Toxicol 2016 Savoca et al., Clin Chem Lab Med 2004
Keep in Mind
- Co-detection is not sufficient evidence to call fluoxetine the cause of a positive.
2 sources Marin et al., J Anal Toxicol 2016 Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
Test Studied
- Syva EMIT II Plus Amphetamines
Tolmetin
Source Joseph et al., J Anal Toxicol 1995
What It Found
- The older EMIT method produced an instrument alarm on specimens containing amphetamines.
Keep in Mind
- The mechanism and direction matter.
- An instrument error or depressed signal is not evidence of a false-positive screen.
- A separate high-concentration TDx benzodiazepine finding is indexed under benzodiazepines.
Tests Studied
- Older Syva EMIT on Hitachi 704
- Compared with Abbott TDx
Tramadol
Source Pope et al., J Anal Toxicol 2023
What It Found
- Tramadol was found in some patients with unconfirmed screens, but added tramadol at 2,500 micrograms/mL remained negative.
Keep in Mind
- Other drugs were often present.
- Co-detection does not show that the prescription caused the clinical result.
Test Studied
- CEDIA Amphetamine/Ecstasy
Bitter orange
Source Nguyen et al., Ther Drug Monit 2006
What It Found
- Urine from six volunteers remained negative after one 900 mg dose of bitter-orange extract standardized to 6% synephrine.
Keep in Mind
- Most samples were collected through six hours.
- The study evaluated one product and dose.
Test Studied
- CEDIA Amphetamines urine assay
Source Łukasik-Głebocka et al., Przegl Lek 2013
What It Found
- A multi-ingredient Thermal Pro overdose case named DMAA or bitter orange components as possible explanations for an unconfirmed amphetamine screen.
Keep in Mind
- Both ingredients and multiple other substances were present.
- The study did not test them separately in this patient's urine.
Test Studied
- Abbott AxSYM amphetamine/methamphetamine FPIA with LC-MS/MS
Amantadine
Source Merigian and Browning, Ann Emerg Med 1993
What It Found
- A historical case report names both amantadine and desipramine in connection with a false-positive result.
Keep in Mind
- The published record does not show that amantadine alone caused the result, and it does not name the test.
Tests Studied
- Urine amphetamine test
- Reagent unverified
Ofloxacin
Source Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09…, 2024
What It Found
- Siemens found no EMIT II Plus interference at 100 micrograms/mL of parent ofloxacin across three cutoffs.
- A separate 2004 study is cited as reporting interference on the older Abbott TDxFLx assay.
Keep in Mind
- The older primary report could not be inspected directly.
- Hold the positive claim for that reagent pending the original.
- The EMIT II Plus negative result is independently documented.
Tests Studied
- EMIT II Plus Amphetamines
- Older Abbott TDxFLx signal awaiting original
Tryptamine
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 3.3% relative response to Tryptamine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS amphetamines urine application on cobas c 501, Table 4
Tested: No False Positive Found
Gabapentin
Source FDA 510(k) K253567. Healgen Accurate Urine Drug Screen Dip Card and Home Urine Drug Test…, 2025
What It Found
- The urine amphetamine dip card did not react with 100 µg/mL of gabapentin.
Keep in Mind
- The negative result applies to the urine antibody test.
Test Studied
- Healgen Accurate urine amphetamine dip card
Source Characterization of an Amphetamine Interference from Gabapentin in an LC-HRMS Method, 2020
What It Found
- In a different method, concentrated gabapentin produced a fragment that could be mistaken for amphetamine by mass spectrometry.
2 sources Characterization of an Amphetamine Interference from Gabapentin in an LC-HRMS Method, 2020 Pervasive Gabapentin Interference in the LC-MS/MS Analysis of Amphetamine, 2018
Keep in Mind
- The confirmation studies found method-specific fragmentation or column overload.
- Updated sample preparation or chromatography resolved the interference.
Test Studied
- Separate LC–HRMS and LC–MS/MS confirmation-method studies
Hydroxychloroquine
Source Gomila et al., Ther Drug Monit 2017
What It Found
- Therapeutically treated patients did not have false positives.
- Parent hydroxychloroquine did not trigger DRI even when added to urine at 1,000 micrograms/mL.
Keep in Mind
- This study distinguished hydroxychloroquine from chloroquine.
- Negative results apply to the assays and conditions tested.
Test Studied
- DRI Amphetamine and comparator immunoassays
Amiphenazole
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- Neither test identified the exposure to Amiphenazole in the authors’ stimulant dosing study.
Keep in Mind
- A negative result on these specific assays does not establish nonreactivity on all amphetamine tests.
Test Studied
- Two historical Abbott amphetamine fluorescence polarization immunoassays
Cropropamide and crotetamide
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- Neither test identified the exposure to Cropropamide and crotetamide in the authors’ stimulant dosing study.
Keep in Mind
- A negative result on these specific assays does not establish nonreactivity on all amphetamine tests.
Test Studied
- Two historical Abbott amphetamine fluorescence polarization immunoassays
Energy drinks in the strip study
Source Shanin et al., Sud Med Ekspert 2012
What It Found
- No urine amphetamine result was detected with this strip after participants consumed 0.5 L of one of the three specified energy drinks.
Keep in Mind
- The study evaluated specific drinks available in Russia in 2012 and one strip.
- Formulations may differ.
Test Studied
- NrcoStop (Osiris S) urine amphetamine strips, 300 ng/mL cutoff
Ethamivan
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- Neither test identified the exposure to Ethamivan in the authors’ stimulant dosing study.
Keep in Mind
- A negative result on these specific assays does not establish nonreactivity on all amphetamine tests.
Test Studied
- Two historical Abbott amphetamine fluorescence polarization immunoassays
Fencamfamin
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- Neither test identified the exposure to Fencamfamin in the authors’ stimulant dosing study.
Keep in Mind
- A negative result on these specific assays does not establish nonreactivity on all amphetamine tests.
Test Studied
- Two historical Abbott amphetamine fluorescence polarization immunoassays
Ginkgo biloba
Source Markowitz et al., J Anal Toxicol 2004
What It Found
- One volunteer taking ginkgo screened positive for amphetamine.
- GC-MS then identified amphetamine in the sample.
- The authors found no evidence that ginkgo caused a false positive.
Keep in Mind
- This was one standardized product in a small group.
- A different formulation or a contaminated supplement is a separate question.
Test Studied
- Beckman Coulter Synchron LX urine enzyme immunoassay and GC-MS
Nikethamide
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- Neither test identified the exposure to Nikethamide in the authors’ stimulant dosing study.
Keep in Mind
- A negative result on these specific assays does not establish nonreactivity on all amphetamine tests.
Test Studied
- Two historical Abbott amphetamine fluorescence polarization immunoassays
Pipradrol
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- Neither test identified the exposure to Pipradrol in the authors’ stimulant dosing study.
Keep in Mind
- A negative result on these specific assays does not establish nonreactivity on all amphetamine tests.
Test Studied
- Two historical Abbott amphetamine fluorescence polarization immunoassays
Prolintane
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- Neither test identified the exposure to Prolintane in the authors’ stimulant dosing study.
Keep in Mind
- A negative result on these specific assays does not establish nonreactivity on all amphetamine tests.
Test Studied
- Two historical Abbott amphetamine fluorescence polarization immunoassays
Strychnine
Source de la Torre et al., J Anal Toxicol 1996
What It Found
- Neither test identified the exposure to Strychnine in the authors’ stimulant dosing study.
Keep in Mind
- A negative result on these specific assays does not establish nonreactivity on all amphetamine tests.
Test Studied
- Two historical Abbott amphetamine fluorescence polarization immunoassays
Thioridazine
Source Crane et al., Clin Chem 1993
What It Found
- All 12 thioridazine-treated patients in a comparison of antipsychotics screened negative on both amphetamine tests.
Keep in Mind
- Other phenothiazines in this same study reacted.
- A class-wide alert would misstate the observed findings.
Test Studied
- Syva EMIT d.a.u. monoclonal and polyclonal amphetamine, 300 ng/mL
2-DPMP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 2-DPMP challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
25B-NBOMe
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 25B-NBOMe challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
25C-NBOMe
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 25C-NBOMe challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
25I-NBOMe
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 25I-NBOMe challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
2C-H
Source Kerrigan et al., J Anal Toxicol 2011
What It Found
- The tested series including 2C-H showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
Keep in Mind
- The tested reagents showed little recognition of these designer compounds despite structural similarity.
- Routine results cannot confirm or exclude the specific exposure.
Test Studied
- Commercial urine stimulant ELISAs tested against 2C, 2C-T and DO psychedelic phenethylamines
2C-N
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- 2C-N did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
2C-T-13
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- 2C-T-13 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
2C-T-17
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- 2C-T-17 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
2C-T-5
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- 2C-T-5 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
3,4-Dimethylmethcathinone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 3,4-Dimethylmethcathinone challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
4-HO-DET
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-HO-DET challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
4-MePPP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-MePPP challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
4-Methoxyphencyclidine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-Methoxyphencyclidine challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
4-MPBP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 4-MPBP challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
5-MeO-DALT
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-MeO-DALT challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
5-MeO-DiPT
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-MeO-DiPT challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
5-MeO-DMT
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the 5-MeO-DMT challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Acetaminophen
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
ALEPH
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- ALEPH did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
ALEPH-13
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- ALEPH-13 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
ALEPH-17
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- ALEPH-17 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
ALEPH-2
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- ALEPH-2 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
ALEPH-5
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- ALEPH-5 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
ALEPH-7
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- ALEPH-7 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
Alpha-PBP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Alpha-PBP challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Alpha-PPP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Alpha-PPP challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Alpha-PVP
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Alpha-PVP challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Alpha-PVT
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Alpha-PVT challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Benocyclidine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Benocyclidine challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
BOB
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- BOB did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
BOD
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- BOD did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
BOH
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- BOH did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
BOHD
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- BOHD did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
Cathinone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Cathinone challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Ciprofloxacin
Source Colby et al., Clin Biochem 2019
What It Found
- Ciprofloxacin added to drug-free urine produced no cross-reaction on the amphetamine/methamphetamine screen in a ten-assay study.
Keep in Mind
- This assay-specific negative result cannot be applied to other quinolones.
Test Studied
- Abbott MULTIGENT amphetamine/methamphetamine
D2PM
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the D2PM challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Dextromethorphan
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Diphenhydramine
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
- Diphenhydramine did not cross the amphetamine cutoff when added at 1,000 ng/mL in one cup study.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Source FDA 510(k) K253567. Healgen Accurate Urine Drug Screen Dip Card and Home Urine Drug Test…, 2025
What It Found
- At 100 µg/mL in Healgen’s urine dip-card study.
Keep in Mind
- Other assays or metabolites require their own evidence.
Test Studied
- Healgen Accurate urine amphetamine dip card
Both sources Lin et al., J Anal Toxicol 2013 FDA 510(k) K253567. Healgen Accurate Urine Drug Screen Dip Card and Home Urine Drug Test…, 2025
Keep in Mind
- These are laboratory challenges of parent diphenhydramine on the tested devices.
DiPT
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the DiPT challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
DON
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- DON did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
DOPR
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- DOPR did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
Epinephrine
Source Podzhilkova et al., Sud Med Ekspert 2020
What It Found
- The prototype amphetamine strip stayed negative when challenged with epinephrine (adrenaline).
Keep in Mind
- The publication gives no unit for the epinephrine challenge and does not specify the preparation of that individual specimen.
- It did not measure patient urine after epinephrine administration.
Test Studied
- Experimental gold-particle amphetamine urine strip evaluated by Podzhilkova and colleagues
Escaline
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Escaline challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
MDBZ
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- MDBZ did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
MDCPM
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- MDCPM did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
MDIP
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- MDIP did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
Meprobamate
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Mescaline
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Mescaline challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Methoxetamine
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Methoxetamine challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
MPHP (study designation)
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the MPHP challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
MT-45
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the MT-45 challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
N,N-Dimethylcathinone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the N,N-Dimethylcathinone challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
Phenylephrine
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- Three amphetamine-class screens in the laboratory comparison showed no reaction to phenylephrine.
Keep in Mind
- The amphetamine table does not give concentrations for these three negative results.
Test Studied
- Beckman, Biosite Triage and Microgenics DRI amphetamine-class screens, supplement tab A, row 44
2 sources Curtin and Cawley, Pharmacotherapy 2012 FDA 510(k) K060896. Varian OnTrak TesTcup II and OnSite CupKit. Decision summary…, 2006
What It Found
- There is separate evidence for a positive on a methamphetamine-specific screen.
Source Curtin and Cawley, Pharmacotherapy 2012
Keep in Mind
- The separate clinical case involved intravenous phenylephrine.
Pyrovalerone
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the Pyrovalerone challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines
TMA-2
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- TMA-2 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
TMA-3
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- TMA-3 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
TMA-6
Source Nieddu et al., J Anal Toxicol 2016
What It Found
- TMA-6 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.
Keep in Mind
- Urine results were evaluated separately from blood and oral fluid.
- Different antibody formulations can give different results.
Test Studied
- Neogen Amphetamine Specific urine ELISA
Trimipramine
Source FDA 510(k) K142353. First Sign Drug of Abuse Dip Card Test and Cup Test. Interference and…, 2014
What It Found
- The FDA submission lists trimipramine among the compounds that did not interfere at 100 micrograms/mL on the amphetamine test.
Keep in Mind
- Some multi-panel documents list positive trimipramine results in the tricyclic antidepressant section.
- Those cannot be assigned to amphetamines.
- A positive amphetamine-specific primary report remains unverified.
Test Studied
- First Sign urine AMP 1000 dip card and cup
Venlafaxine
Source Pope et al., J Anal Toxicol 2023
What It Found
- The parent drug tested negative at 2,500 micrograms/mL in a CEDIA experiment.
Keep in Mind
- The result concerns this assay and parent venlafaxine.
- Other drug-test targets have different evidence.
Test Studied
- CEDIA Amphetamine/Ecstasy, 300 ng/mL cutoff
WIN 35,428
Source Regester et al., J Anal Toxicol 2015
What It Found
- In the WIN 35,428 challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
Keep in Mind
- These were pure reference compounds added to drug-free human urine.
- The concentrations do not predict a positive result after use in a patient.
Test Studied
- Urine screening on Roche/Hitachi Modular P, CEDIA DAU Amphetamine/Ecstasy and Syva EMIT II Plus Amphetamines